Medications for human use with a single active ingredient starting with the letter S-Z.

Médicaments à usage humain contenant un seul ingrédient actif commençant par la lettre S-Z.

Updated | Mise à jour : 2021-07-04
∙ Product name | Nom du produit;
∙ Active ingredient(s) and concentration | Ingrédient(s) actif(s) et concentration;
∙ Original market date | Date de commercialisation originale;
∙ Route(s) of administration | Voie(s) d’administration;
∙ Dosage form(s) | Forme(s) posologique(s);
∙ AHFS;
∙ Schedule(s) | Annexe(s);
∙ Company | Entreprise;
∙ DIN
Monograph | Monographie
ONSTRYV;
safinamide (safinamide mesylate) 100 mg;
2019-07-08;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
VALEO PHARMA INC
DIN: 02484668
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97495
ONSTRYV;
safinamide (safinamide mesylate) 50 mg;
2019-07-08;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
VALEO PHARMA INC
DIN: 02484641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97492
PMS-SALBUTAMOL;
salbutamol (salbutamol sulfate) 0.5 mg / ml;
1996-12-31;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02208245
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19761
TEVA-SALBUTAMOL STERINEBS P.F.;
salbutamol (salbutamol sulfate) 1 mg / ml;
1992-12-31;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 01926934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13550
PMS-SALBUTAMOL;
salbutamol (salbutamol sulfate) 1 mg / ml;
1996-12-31;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02208229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19763
VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML);
salbutamol (salbutamol sulfate) 1 mg / ml;
1999-05-24;
Intravenous;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02213451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43104
AIROMIR;
salbutamol (salbutamol sulfate) 100 mcg / act;
1998-08-13;
Inhalation;
Metered-Dose Aerosol;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02232570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=52048
VENTOLIN HFA;
salbutamol (salbutamol sulfate) 100 mcg / act;
2001-11-22;
Inhalation;
Metered-Dose Aerosol;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02241497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65137
APO-SALBUTAMOL HFA;
salbutamol (salbutamol sulfate) 100 mcg / act;
2002-08-22;
Inhalation;
Metered-Dose Aerosol;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
APOTEX INC
DIN: 02245669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69769
TEVA-SALBUTAMOL HFA;
salbutamol (salbutamol sulfate) 100 mcg / act;
2009-12-31;
Inhalation;
Metered-Dose Aerosol;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02326450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81180
SALBUTAMOL HFA;
salbutamol (salbutamol sulfate) 100 mcg / act;
2014-02-13;
Inhalation;
Metered-Dose Aerosol;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02419858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90447
TEVA-SALBUTAMOL STERINEBS P.F.;
salbutamol (salbutamol sulfate) 2 mg / ml;
1995-12-31;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02173360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19058
PMS-SALBUTAMOL;
salbutamol (salbutamol sulfate) 2 mg / ml;
1996-12-31;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02208237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19762
VENTOLIN NEBULES P.F. – 2.5MG/2.5ML;
salbutamol (salbutamol sulfate) 2.5 mg / 2.5 ml;
2000-05-21;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02213419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43100
VENTOLIN DISKUS;
salbutamol (salbutamol sulfate) 200 mcg / act;
2001-01-02;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02243115
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66984
VENTOLIN RESPIRATOR SOLUTION;
salbutamol (salbutamol sulfate) 5 mg / ml;
1998-12-01;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02213486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43108
VENTOLIN NEBULES P.F. – 5MG/2.5ML;
salbutamol (salbutamol sulfate) 5 mg / 2.5 ml;
2000-10-02;
Inhalation;
Solution;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02213427
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43101
SEREVENT DISKUS (50MCG/DOSE);
salmeterol (salmeterol xinafoate) 50 mcg / act;
1998-04-01;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02231129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50436
TYPHIM VI;
salmonella typhi vi capsular polysaccharide vaccine 25 mcg / 0.5 ml;
1995-12-31;
Intramuscular;
Solution;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 02130955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20287
KUVAN;
sapropterin dihydrochloride 100 mg;
2010-07-05;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BIOMARIN INTERNATIONAL LIMITED
DIN: 02350580
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83577
KUVAN;
sapropterin dihydrochloride 100 mg / sachet;
2019-12-05;
Oral;
Powder;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BIOMARIN INTERNATIONAL LIMITED
DIN: 02482207
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97268
KUVAN;
sapropterin dihydrochloride 500 mg / sachet;
2019-12-05;
Oral;
Powder;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BIOMARIN INTERNATIONAL LIMITED
DIN: 02482215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97269
KEVZARA;
sarilumab 150 mg / 1.14 ml;
2017-03-29;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02460521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94796
KEVZARA;
sarilumab 150 mg / 1.14 ml;
2018-06-21;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02472961
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96232
KEVZARA;
sarilumab 200 mg / 1.14 ml;
2017-02-08;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02460548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94797
KEVZARA;
sarilumab 200 mg / 1.14 ml;
2018-06-21;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02472988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96233
ENSPRYNG;
satralizumab 120 mg / ml;
2020-08-26;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02499681
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98941
ONGLYZA;
saxagliptin (saxagliptin hydrochloride) 2.5 mg;
2011-12-23;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02375842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86124
SANDOZ SAXAGLIPTIN;
saxagliptin (saxagliptin hydrochloride) 2.5 mg;
2021-03-08;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02468603
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95702
APO-SAXAGLIPTIN;
saxagliptin (saxagliptin hydrochloride) 2.5 mg;
2021-03-29;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
APOTEX INC
DIN: 02507471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99686
ONGLYZA;
saxagliptin (saxagliptin hydrochloride) 5 mg;
2009-10-29;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02333554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81917
SANDOZ SAXAGLIPTIN;
saxagliptin (saxagliptin hydrochloride) 5 mg;
2021-03-08;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02468611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95703
APO-SAXAGLIPTIN;
saxagliptin (saxagliptin hydrochloride) 5 mg;
2021-03-29;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
APOTEX INC
DIN: 02507498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99687
SCOPOLAMINE HYDROBROMIDE INJECTION;
scopolamine hydrobromide 0.4 mg / ml;
2008-05-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02242810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66635
SCOPOLAMINE HYDROBROMIDE INJECTION;
scopolamine hydrobromide 0.6 mg / ml;
2008-07-08;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02242811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66636
KANUMA;
sebelipase alfa 2 mg / ml;
2018-04-05;
Intravenous;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
ALEXION PHARMA GMBH
DIN: 02469596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95840
COSENTYX;
secukinumab 150 mg / ml;
2015-04-10;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02438070
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92243
SELEGILINE;
selegiline hydrochloride 5 mg;
1997-02-13;
Oral;
Tablet;
28:36.32 – MONOAMINE OXIDASE B INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 02230641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49813
MICRO SE;
selenium (selenious acid) 40 mcg / ml;
1993-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 01986007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13559
UPTRAVI;
selexipag 1000 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
DIN: 02451190
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93745
UPTRAVI;
selexipag 1200 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
DIN: 02451204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93746
UPTRAVI;
selexipag 1400 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
DIN: 02451212
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93747
UPTRAVI;
selexipag 1600 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
DIN: 02451220
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93748
UPTRAVI;
selexipag 200 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
DIN: 02451158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93741
UPTRAVI;
selexipag 400 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
DIN: 02451166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93742
UPTRAVI;
selexipag 600 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
DIN: 02451174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93743
UPTRAVI;
selexipag 800 mcg;
2016-04-21;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
DIN: 02451182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93744
OZEMPIC;
semaglutide 1 mg / act;
2018-02-22;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02471469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96058
OZEMPIC;
semaglutide 1.34 mg / ml;
2018-02-22;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02471477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96059
RYBELSUS;
semaglutide 14 mg;
2020-04-19;
Oral;
Tablet;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02497611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98742
RYBELSUS;
semaglutide 3 mg;
2020-04-19;
Oral;
Tablet;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02497581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98740
RYBELSUS;
semaglutide 7 mg;
2020-04-19;
Oral;
Tablet;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02497603
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98741
ZOLOFT;
sertraline (sertraline hydrochloride) 100 mg;
1992-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 01962779
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13392
APO-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
1999-09-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02238282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61678
TEVA-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
1999-08-16;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02240481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64051
SERTRALINE-100;
sertraline (sertraline hydrochloride) 100 mg;
2001-02-15;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02241304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64920
PMS-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2002-01-30;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02244840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68830
SANDOZ SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2002-02-13;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02245161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69174
RIVA-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2005-01-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02248498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72850
SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2010-08-03;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02353547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83876
SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2012-06-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386097
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87168
AURO-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2012-10-18;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02390922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87631
MAR-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2014-01-16;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02399431
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88432
MINT-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2013-04-29;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02402408
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88723
BIO-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2016-12-08;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02445069
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93027
PRIVA-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2016-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02445387
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93063
SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2018-01-17;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02469642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95844
AG-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2018-09-06;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02477904
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96811
NRA-SERTRALINE;
sertraline (sertraline hydrochloride) 100 mg;
2019-09-04;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02488450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97854
ZOLOFT;
sertraline (sertraline hydrochloride) 25 mg;
1995-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 02132702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18005
APO-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
1999-09-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02238280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61676
TEVA-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
1999-08-16;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02240485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64055
SERTRALINE-25;
sertraline (sertraline hydrochloride) 25 mg;
2001-02-15;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02241302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64918
PMS-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2002-01-30;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02244838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68828
SANDOZ SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2002-02-13;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02245159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69170
RIVA-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2005-01-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02248496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72848
SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2010-08-03;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02353520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83874
SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2012-06-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386070
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87166
AURO-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2012-10-18;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02390906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87629
MAR-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2014-01-16;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02399415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88430
MINT-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2013-04-29;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02402378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88721
BIO-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2016-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02445042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93025
PRIVA-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2016-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02445352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93058
SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2018-01-17;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02469626
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95842
AG-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2018-09-06;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02477882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96809
NRA-SERTRALINE;
sertraline (sertraline hydrochloride) 25 mg;
2019-09-04;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02488434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97852
ZOLOFT;
sertraline (sertraline hydrochloride) 50 mg;
1992-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 01962817
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12662
APO-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
1999-09-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02238281
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61677
TEVA-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
1999-08-16;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02240484
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64054
SERTRALINE-50;
sertraline (sertraline hydrochloride) 50 mg;
2001-02-15;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02241303
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64919
PMS-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2002-01-30;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02244839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68829
SANDOZ SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2002-02-13;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02245160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69172
RIVA-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2005-10-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02248497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72849
SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2010-08-03;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02353539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83875
SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2012-06-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386089
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87167
AURO-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2012-10-18;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02390914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87630
MAR-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2014-01-06;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02399423
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88431
MINT-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2013-04-29;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02402394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88722
BIO-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2016-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02445050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93026
PRIVA-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2016-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02445360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93062
SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2018-01-17;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02469634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95843
AG-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2018-09-06;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02477890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96810
NRA-SERTRALINE;
sertraline (sertraline hydrochloride) 50 mg;
2019-09-04;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02488442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97853
RENVELA;
sevelamer carbonate 0.8 g / sachet;
2019-10-25;
Oral;
Powder For Suspension;
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02485559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97579
RENVELA;
sevelamer carbonate 2.4 g / sachet;
2019-10-25;
Oral;
Powder For Suspension;
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02485567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97580
RENVELA;
sevelamer carbonate 800 mg;
2010-11-25;
Oral;
Tablet;
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02354586
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83974
ACCEL-SEVELAMER;
sevelamer carbonate 800 mg;
2017-11-08;
Oral;
Tablet;
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
ACCEL PHARMA INC
DIN: 02461501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94913
RENAGEL;
sevelamer hydrochloride 800 mg;
2001-11-21;
Oral;
Tablet;
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02244310
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68278
SEVORANE AF;
sevoflurane 99.97 %;
1995-12-31;
Inhalation;
Liquid;
28:04.16 – INHALATION ANESTHETICS;
Prescription;
ABBVIE CORPORATION
DIN: 02172763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19497
SEVOFLURANE;
sevoflurane 99.97 %;
2007-04-11;
Inhalation;
Liquid;
28:04.16 – INHALATION ANESTHETICS;
Prescription;
BAXTER CORPORATION
DIN: 02265974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75141
SOJOURN SEVOFLURANE;
sevoflurane 99.97 %;
2009-11-18;
Inhalation;
Liquid;
28:04.16 – INHALATION ANESTHETICS;
Prescription;
PIRAMAL CRITICAL CARE INC
DIN: 02307766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79344
REVATIO;
sildenafil (sildenafil citrate) 0.8 mg / ml;
2010-08-31;
Intravenous;
Solution;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 02341611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82711
VIAGRA;
sildenafil (sildenafil citrate) 100 mg;
1999-03-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 02239768
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63250
APO-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2012-11-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02248203
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72539
TEVA-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2012-11-08;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02308754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79437
SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2013-08-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02317583
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80311
MINT-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2013-02-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02393085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87833
MAR-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2017-01-11;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02402548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88737
JAMP-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2014-12-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02405687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89045
SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2013-06-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02406160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89089
AURO-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2019-05-17;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02414384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89904
SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2014-10-07;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02424320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90903
M-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2015-06-04;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02430037
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91445
PRIVA-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2016-09-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02448807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93454
RIVA-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2016-05-06;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02452413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93880
PRZ-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2018-05-02;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMARIS CANADA INC
DIN: 02468557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95698
NRA-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2018-12-04;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
NORA PHARMA INC
DIN: 02476819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96718
ACCEL-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2019-08-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ACCEL PHARMA INC
DIN: 02479826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97041
AG-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97094
BIO-SILDENAFIL;
sildenafil (sildenafil citrate) 100 mg;
2019-07-02;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02480980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97103
JAMP SILDENAFIL TABLETS;
sildenafil (sildenafil citrate) 100 mg;
2021-01-27;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02503506
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99297
REVATIO;
sildenafil (sildenafil citrate) 20 mg;
2006-06-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 02279401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76500
TEVA-SILDENAFIL R;
sildenafil (sildenafil citrate) 20 mg;
2010-06-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02319500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80498
PMS-SILDENAFIL R;
sildenafil (sildenafil citrate) 20 mg;
2014-11-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02412179
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89674
JAMP-SILDENAFIL R;
sildenafil (sildenafil citrate) 20 mg;
2021-02-08;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02469669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95846
VIAGRA;
sildenafil (sildenafil citrate) 25 mg;
1999-03-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 02239766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63248
APO-SILDENAFIL;
sildenafil (sildenafil citrate) 25 mg;
2012-11-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02248201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72537
TEVA-SILDENAFIL;
sildenafil (sildenafil citrate) 25 mg;
2012-11-08;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02308738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79435
SILDENAFIL;
sildenafil (sildenafil citrate) 25 mg;
2013-08-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02317559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80308
JAMP-SILDENAFIL;
sildenafil (sildenafil citrate) 25 mg;
2014-12-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02405660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89043
AURO-SILDENAFIL;
sildenafil (sildenafil citrate) 25 mg;
2019-05-17;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02414368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89902
ACCEL-SILDENAFIL;
sildenafil (sildenafil citrate) 25 mg;
2019-08-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ACCEL PHARMA INC
DIN: 02479796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97038
AG-SILDENAFIL;
sildenafil (sildenafil citrate) 25 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480395
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97092
VIAGRA;
sildenafil (sildenafil citrate) 50 mg;
1999-03-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 02239767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63249
APO-SILDENAFIL;
sildenafil (sildenafil citrate) 50 mg;
2012-11-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02248202
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72538
TEVA-SILDENAFIL;
sildenafil (sildenafil citrate) 50 mg;
2012-11-08;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02308746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79436
SILDENAFIL;
sildenafil (sildenafil citrate) 50 mg;
2013-08-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02317575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80310
MINT-SILDENAFIL;
sildenafil (sildenafil citrate) 50 mg;
2013-02-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02393077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87832
JAMP-SILDENAFIL;
sildenafil (sildenafil citrate) 50 mg;
2014-12-05;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02405679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89044
SILDENAFIL;
sildenafil (sildenafil citrate) 50 mg;
2013-06-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02406152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89088
AURO-SILDENAFIL;
sildenafil (sildenafil citrate) 50 mg;
2019-05-17;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02414376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89903
SILDENAFIL;
sildenafil (sildenafil citrate) 50 mg;
2014-10-07;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02424312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90902
ACCEL-SILDENAFIL;
sildenafil (sildenafil citrate) 50 mg;
2019-08-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ACCEL PHARMA INC
DIN: 02479818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97040
AG-SILDENAFIL;
sildenafil (sildenafil citrate) 50 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97093
BARRIERE CREAM 20%;
silicone 20 %;
1997-04-01;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
WELLSPRING PHARMACEUTICAL CANADA CORP
DIN: 02060841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27514
RAPAFLO;
silodosin 4 mg;
2011-10-26;
Oral;
Capsule;
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
ALLERGAN INC
DIN: 02361663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84673
SANDOZ SILODOSIN;
silodosin 4 mg;
2021-01-08;
Oral;
Capsule;
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02475421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96581
RAPAFLO;
silodosin 8 mg;
2011-10-26;
Oral;
Capsule;
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
ALLERGAN INC
DIN: 02361671
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84674
SANDOZ SILODOSIN;
silodosin 8 mg;
2021-01-08;
Oral;
Capsule;
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02475448
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96582
SYLVANT;
siltuximab 100 mg / vial;
2015-03-03;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
EUSA PHARMA (UK) LIMITED
DIN: 02435128
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91940
SYLVANT;
siltuximab 400 mg / vial;
2015-03-03;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
EUSA PHARMA (UK) LIMITED
DIN: 02435136
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91941
FLAMAZINE CRM 1%;
silver sulfadiazine 1 %;
1974-12-31;
Topical;
Cream;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Prescription;
SMITH & NEPHEW INC
DIN: 00323098
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2146
GAS-X EXTRA STRENGTH;
simethicone 125 mg;
1991-12-31;
Oral;
Tablet (Chewable);
56:10.00 – ANTIFLATULENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 00896675
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13362
GAS RELIEF TABLETS;
simethicone 125 mg;
2010-03-25;
Oral;
Tablet (Chewable);
56:10.00 – ANTIFLATULENTS;
Otc;
GUARDIAN DRUG COMPANY INC
DIN: 02328127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81363
ULTRA STRENGTH PHAZYME 180MG SOFTGELS;
simethicone 180 mg;
1998-10-27;
Oral;
Capsule;
56:10.00 – ANTIFLATULENTS;
Otc;
C B FLEET COMPANY INC
DIN: 02237698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61044
OVOL FOR GAS 180 MG CAPSULE;
simethicone 180 mg;
1999-03-30;
Oral;
Capsule;
56:10.00 – ANTIFLATULENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 02239298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62764
ULTRA STRENGTH GAS RELIEF;
simethicone 180 mg;
2001-09-01;
Oral;
Capsule;
56:10.00 – ANTIFLATULENTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02244204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68167
OVOL FOR GAS 180 MG TABLET;
simethicone 180 mg;
2003-05-16;
Oral;
Tablet;
56:10.00 – ANTIFLATULENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 02247127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71367
GAS X ULTRA STRENGTH;
simethicone 180 mg;
2008-02-22;
Oral;
Capsule;
56:10.00 – ANTIFLATULENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02300761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78612
OVOL DROPS;
simethicone 40 mg / ml;
1963-12-31;
Oral;
Drops;
56:10.00 – ANTIFLATULENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 00013617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=198
PEDIACOL;
simethicone 40 mg / ml;
2004-05-21;
Oral;
Drops;
56:10.00 – ANTIFLATULENTS;
Otc;
EURO-PHARM INTERNATIONAL CANADA INC
DIN: 02245510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69597
INFACOL;
simethicone 40 mg / ml;
2006-07-27;
Oral;
Suspension;
56:10.00 – ANTIFLATULENTS;
Otc;
LEDA HEALTH INNOVATIONS INC.
DIN: 02248588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72943
OVOL FOR GAS 80 MG TABLET;
simethicone 80 mg;
1974-12-31;
Oral;
Tablet;
56:10.00 – ANTIFLATULENTS;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 00292990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1889
ZOCOR;
simvastatin 10 mg;
1990-12-31;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ORGANON CANADA INC.
DIN: 00884332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10947
APO-SIMVASTATIN;
simvastatin 10 mg;
2002-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02247012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71246
SIMVASTATIN-10;
simvastatin 10 mg;
2003-04-10;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02247221
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71463
TEVA-SIMVASTATIN;
simvastatin 10 mg;
2004-03-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02250152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73496
SIMVASTATIN;
simvastatin 10 mg;
2009-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02284731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77029
TARO-SIMVASTATIN;
simvastatin 10 mg;
2009-07-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02329158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81484
MINT-SIMVASTATIN;
simvastatin 10 mg;
2011-09-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02372940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85805
MAR-SIMVASTATIN;
simvastatin 10 mg;
2012-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02375044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86044
JAMP-SIMVASTATIN;
simvastatin 10 mg;
2012-01-09;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02375605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86102
SIMVASTATIN;
simvastatin 10 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87188
AURO-SIMVASTATIN;
simvastatin 10 mg;
2013-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02405156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88998
PHARMA-SIMVASTATIN;
simvastatin 10 mg;
2017-11-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02469987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95893
AG-SIMVASTATIN;
simvastatin 10 mg;
2018-09-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480069
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97060
BIO-SIMVASTATIN;
simvastatin 10 mg;
2019-09-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02484455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97477
PRIVA-SIMVASTATIN;
simvastatin 10 mg;
2019-08-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02485745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97598
ZOCOR;
simvastatin 20 mg;
1994-12-31;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ORGANON CANADA INC.
DIN: 00884340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16473
APO-SIMVASTATIN;
simvastatin 20 mg;
2002-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02247013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71247
SIMVASTATIN-20;
simvastatin 20 mg;
2003-04-10;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02247222
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71464
TEVA-SIMVASTATIN;
simvastatin 20 mg;
2004-03-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02250160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73497
PMS-SIMVASTATIN;
simvastatin 20 mg;
2005-11-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02269279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75465
SIMVASTATIN;
simvastatin 20 mg;
2009-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02284758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77030
TARO-SIMVASTATIN;
simvastatin 20 mg;
2009-07-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02329166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81485
MINT-SIMVASTATIN;
simvastatin 20 mg;
2011-09-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02372959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85806
MAR-SIMVASTATIN;
simvastatin 20 mg;
2012-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02375052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86045
JAMP-SIMVASTATIN;
simvastatin 20 mg;
2012-01-09;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02375613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86103
SIMVASTATIN;
simvastatin 20 mg;
2012-06-12;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87189
AURO-SIMVASTATIN;
simvastatin 20 mg;
2013-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02405164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88999
PHARMA-SIMVASTATIN;
simvastatin 20 mg;
2017-11-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02469995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95894
AG-SIMVASTATIN;
simvastatin 20 mg;
2018-09-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97062
BIO-SIMVASTATIN;
simvastatin 20 mg;
2019-09-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02484463
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97478
PRIVA-SIMVASTATIN;
simvastatin 20 mg;
2019-08-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02485753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97599
ZOCOR;
simvastatin 40 mg;
1996-08-14;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ORGANON CANADA INC.
DIN: 00884359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46718
APO-SIMVASTATIN;
simvastatin 40 mg;
2002-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02247014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71248
SIMVASTATIN-40;
simvastatin 40 mg;
2003-04-10;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02247223
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71465
TEVA-SIMVASTATIN;
simvastatin 40 mg;
2004-03-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02250179
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73498
PMS-SIMVASTATIN;
simvastatin 40 mg;
2005-11-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02269287
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75466
SIMVASTATIN;
simvastatin 40 mg;
2009-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02284766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77031
TARO-SIMVASTATIN;
simvastatin 40 mg;
2009-07-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02329174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81486
MINT-SIMVASTATIN;
simvastatin 40 mg;
2011-09-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02372967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85807
MAR-SIMVASTATIN;
simvastatin 40 mg;
2012-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02375060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86046
JAMP-SIMVASTATIN;
simvastatin 40 mg;
2012-01-09;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02375621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86104
SIMVASTATIN;
simvastatin 40 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87190
AURO-SIMVASTATIN;
simvastatin 40 mg;
2013-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02405172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88997
PHARMA-SIMVASTATIN;
simvastatin 40 mg;
2017-11-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02470004
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95895
AG-SIMVASTATIN;
simvastatin 40 mg;
2018-09-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97061
BIO-SIMVASTATIN;
simvastatin 40 mg;
2019-09-19;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
BIOMED PHARMA
DIN: 02484471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97479
PRIVA-SIMVASTATIN;
simvastatin 40 mg;
2019-08-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02485761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97600
APO-SIMVASTATIN;
simvastatin 5 mg;
2002-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02247011
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71245
TEVA-SIMVASTATIN;
simvastatin 5 mg;
2004-03-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02250144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73495
PMS-SIMVASTATIN;
simvastatin 5 mg;
2005-11-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02269252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75463
SIMVASTATIN;
simvastatin 5 mg;
2009-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02284723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77028
TARO-SIMVASTATIN;
simvastatin 5 mg;
2009-07-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02329131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81483
MINT-SIMVASTATIN;
simvastatin 5 mg;
2011-09-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02372932
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85804
JAMP-SIMVASTATIN;
simvastatin 5 mg;
2012-01-09;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02375591
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86101
SIMVASTATIN;
simvastatin 5 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386291
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87187
AURO-SIMVASTATIN;
simvastatin 5 mg;
2013-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02405148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88996
PHARMA-SIMVASTATIN;
simvastatin 5 mg;
2017-11-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02469979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95892
AG-SIMVASTATIN;
simvastatin 5 mg;
2018-09-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97059
APO-SIMVASTATIN;
simvastatin 80 mg;
2002-12-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02247015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71249
SIMVASTATIN-80;
simvastatin 80 mg;
2009-06-15;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02247224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71466
TEVA-SIMVASTATIN;
simvastatin 80 mg;
2004-03-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02250187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73499
PMS-SIMVASTATIN;
simvastatin 80 mg;
2005-11-03;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02269295
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75467
SIMVASTATIN;
simvastatin 80 mg;
2009-10-22;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02284774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77032
TARO-SIMVASTATIN;
simvastatin 80 mg;
2009-07-20;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02329182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81487
MINT-SIMVASTATIN;
simvastatin 80 mg;
2011-09-07;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02372975
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85808
JAMP-SIMVASTATIN;
simvastatin 80 mg;
2012-01-09;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02375648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86105
SIMVASTATIN;
simvastatin 80 mg;
2012-06-11;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87191
AURO-SIMVASTATIN;
simvastatin 80 mg;
2013-07-08;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02405180
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89000
PHARMA-SIMVASTATIN;
simvastatin 80 mg;
2017-11-29;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02470012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95896
AG-SIMVASTATIN;
simvastatin 80 mg;
2018-09-06;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02480093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97063
KINEVAC;
sincalide 5 mcg / vial;
1998-07-08;
Intravenous;
Powder For Solution;
36:34.00 – GALLBLADDER FUNCTION;
Ethical;
BRACCO IMAGING CANADA
DIN: 02228602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37574
VEREGEN;
sinecatechins 10 % / w/w;
2014-07-04;
Topical;
Ointment;
84:04.06 – ANTIVIRALS;
Prescription;
PALADIN LABS INC.
DIN: 02411849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89643
MAYZENT;
siponimod 0.25 mg;
2020-04-24;
Oral;
Tablet;
92:20.00 – Immunomodulatory Agents;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02496429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98630
MAYZENT;
siponimod 2 mg;
2020-04-24;
Oral;
Tablet;
92:20.00 – Immunomodulatory Agents;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02496437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98631
RAPAMUNE;
sirolimus 1 mg;
2003-03-25;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02247111
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71350
RAPAMUNE;
sirolimus 1 mg / ml;
2001-05-15;
Oral;
Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02243237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67127
JANUVIA;
sitagliptin (sitagliptin phosphate monohydrate) 100 mg;
2008-01-02;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02303922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78924
JANUVIA;
sitagliptin (sitagliptin phosphate monohydrate) 25 mg;
2012-09-17;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02388839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87438
JANUVIA;
sitagliptin (sitagliptin phosphate monohydrate) 50 mg;
2012-09-17;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02388847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87439
SODIUM ACETATE INJECTION, USP;
sodium acetate 328 mg / ml;
1996-08-14;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02139529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31360
SODIUM ACETATE-OMEGA;
sodium acetate 328 mg / ml;
1999-05-28;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02181746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35083
BICART;
sodium bicarbonate 1250 g / cartridge;
2013-10-22;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 02403501
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88830
SODIUM BICARBONATE INJECTION USP;
sodium bicarbonate 42 mg / ml;
1987-12-31;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
PFIZER CANADA ULC
DIN: 00261971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8350
SODIUM BICARBONATE INJECTION, USP;
sodium bicarbonate 42 mg / ml;
2019-10-04;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02486628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97680
HEMA BP-38;
sodium bicarbonate 6 kg / container;
2006-07-03;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
CHIEF MEDICAL SUPPLIES LTD
DIN: 02280884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76654
BIBAG;
sodium bicarbonate 650 g / bag;
2009-12-10;
Dialysis;
Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
FRESENIUS MEDICAL CARE CANADA INC
DIN: 02325586
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81095
HEMACART;
sodium bicarbonate 650 g / cartridge;
2009-12-21;
Dialysis;
Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
CHIEF MEDICAL SUPPLIES LTD
DIN: 02325772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81113
SODIUM BICARBONATE USP FOR HEMODIALYSIS D12276;
sodium bicarbonate 650 g / sachet;
1996-09-10;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 02221616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37283
800 SODIUM BICARBONATE POWDER;
sodium bicarbonate 650 g / 8 l;
1988-12-31;
Dialysis;
Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 00774995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8587
BICART;
sodium bicarbonate 720 g / cartridge;
2013-09-26;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 02403498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88829
SODIUM BICARBONATE INJECTION USP;
sodium bicarbonate 75 mg / ml;
1979-12-31;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
PFIZER CANADA ULC
DIN: 00038083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3837
BICARBONATE CONCENTRATE B38;
sodium bicarbonate 80.7 g / l;
2005-07-04;
Dialysis;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
CHIEF MEDICAL SUPPLIES LTD
DIN: 02248934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73309
BICARBONATE CONCENTRATE D17000;
sodium bicarbonate 81.3 g / l;
1986-12-31;
Dialysis;
Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 00691623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6775
SODIUM BICARBONATE INJECTION USP;
sodium bicarbonate 84 mg / ml;
1974-12-31;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
PFIZER CANADA ULC
DIN: 00261998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1905
SODIUM BICARBONATE INJECTION USP;
sodium bicarbonate 84 mg / ml;
2017-10-20;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02467585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95595
SODIUM BICARBONATE INJECTION, USP;
sodium bicarbonate 84 mg / ml;
2019-09-17;
Intravenous;
Solution;
40:08.00 – ALKALINIZING AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02486636
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97681
BIBAG;
sodium bicarbonate 900 g / bag;
2020-01-30;
Dialysis;
Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
FRESENIUS MEDICAL CARE CANADA INC
DIN: 02487756
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97789
0.9% SODIUM CHLORIDE INJECTION USP;
sodium chloride 0.9 %;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 01924303
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12185
SODIUM CHLORIDE INJECTION USP;
sodium chloride 0.9 % / w/v;
2009-04-06;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS MEDICAL CARE NORTH AMERICA
DIN: 02311798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79733
1.6% SODIUM CHLORDIE PROCESSING SOLUTION;
sodium chloride 1.6 g / 100 ml;
1991-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
DIN: 00783633
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12169
12% SODIUM CHLORDIE PROCESSING SOLUTION;
sodium chloride 12 g / 100 ml;
1991-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
DIN: 00783625
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12168
SODIUM CHLORIDE INJ 23.4%;
sodium chloride 234 mg / ml;
1977-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 00402230
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3395
SODIUM CHLORIDE INJECTION, USP;
sodium chloride 234 mg / ml;
1984-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02139510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18937
SODIUM CHLORIDE 3% INJ;
sodium chloride 3 g / 100 ml;
1990-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 00060232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11039
SODIUM CHLORIDE INJECTION USP;
sodium chloride 4.5 mg / ml;
1960-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00037788
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1736
0.45% SODIUM CHLORIDE INJECTION USP;
sodium chloride 4.5 mg / ml;
1993-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 01927949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14579
SODIUM CHLORIDE 0.45% INJ;
sodium chloride 450 mg / 100 ml;
1990-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 00060186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10442
5% SODIUM CHLORIDE INJECTION USP;
sodium chloride 5 g / 100 ml;
1993-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 01928007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15492
H.E.L.P. NACI 0.9%;
sodium chloride 9 g / l;
2012-03-09;
0-Unassigned;
Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
B. BRAUN AVITUM AG
DIN: 02373815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85903
BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP;
sodium chloride 9 mg / ml;
1951-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
DIN: 00037818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=115
SODIUM CHLORIDE IRRIGATION USP;
sodium chloride 9 mg / ml;
1966-12-31;
Intraperitoneal , Irrigation , Topical;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00037834
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=228
SODIUM CHLORIDE INJECTION USP;
sodium chloride 9 mg / ml;
1967-12-31;
Intramuscular , Intraperitoneal , Intravenous , Subcutaneous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
PFIZER CANADA ULC
DIN: 00037796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=817
SODIUM CHLORIDE IRRIGATION USP;
sodium chloride 9 mg / ml;
1964-12-31;
Intraperitoneal , Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00037826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1239
SODIUM CHLORIDE BACTERIOSTATIC INJ;
sodium chloride 9 mg / ml;
1977-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 00402249
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3396
SODIUM CHLORIDE INJECTION USP;
sodium chloride 9 mg / ml;
1980-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00037842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4092
0.9% SODIUM CHLORIDE INJECTION USP;
sodium chloride 9 mg / ml;
1977-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02150204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18136
SODIUM CHLORIDE INJECTION USP 0.9%;
sodium chloride 9 mg / ml;
2006-08-17;
Intravenous , Subcutaneous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FERRING INC
DIN: 02279754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76534
SODIUM CHLORIDE INJECTION USP 0.9%;
sodium chloride 9 mg / ml;
2008-06-06;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:50.00* – DILUENTS;
Ethical;
TELIGENT OU
DIN: 02304341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78963
0.9% SODIUM CHLORIDE IRRIGATION, USP;
sodium chloride 900 mg / 100 ml;
1989-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
DIN: 00786160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9825
0.9% SODIUM CHLORIDE INJECTION, USP;
sodium chloride 900 mg / 100 ml;
1982-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
BAXTER CORPORATION
DIN: 00060208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10040
SODIUM CHLORIDE 0.9% INJECTION;
sodium chloride 900 mg / 100 ml;
2013-12-10;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02395150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88027
ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML;
sodium citrate 4 g / 100 ml;
1990-12-31;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
BAXTER CORPORATION
DIN: 00060313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10497
ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP;
sodium citrate dihydrate 4 g / 100 ml;
2012-10-01;
0-Unassigned;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Ethical;
HAEMONETICS CORPORATION
DIN: 02377411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86313
NIPRIDE;
sodium nitroprusside 25 mg / ml;
2011-05-17;
Intravenous;
Solution;
24:08.20 – DIRECT VASODILATORS;
Prescription;
PFIZER CANADA ULC
DIN: 02361736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84678
SODIUM NITROPRUSSIDE FOR INJECTION;
sodium nitroprusside 25 mg / ml;
2021-04-26;
Intravenous;
Solution;
24:08.20 – DIRECT VASODILATORS;
Prescription;
STERIMAX INC
DIN: 02450089
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93610
SODIUM NITROPRUSSIDE FOR INJECTION;
sodium nitroprusside 25 mg / ml;
2019-04-15;
Intravenous;
Solution;
24:08.20 – DIRECT VASODILATORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02479109
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96981
SODIUM NITROPRUSSIDE FOR INJECTION;
sodium nitroprusside 25 mg / ml;
2021-05-26;
Intravenous;
Solution;
24:08.20 – DIRECT VASODILATORS;
Prescription;
DR REDDY’S LABORATORIES LTD
DIN: 02507404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99680
XYREM;
sodium oxybate 500 mg / ml;
2007-08-03;
Oral;
Solution;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Schedule G (Cdsa I);
JAZZ PHARMACEUTICALS IRELAND LIMITED
DIN: 02268272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75367
PHEBURANE;
sodium phenylbutyrate 483 mg / g;
2015-01-27;
Oral;
Granules;
-;
Prescription;
MEDUNIK CANADA
DIN: 02436663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92099
SOLYSTAT;
sodium polystyrene sulfonate 1 g / g;
1988-12-31;
Oral , Rectal;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00755338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8918
KAYEXALATE;
sodium polystyrene sulfonate 1 g / g;
1961-12-31;
Oral , Rectal;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02026961
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17752
ODAN-SODIUM POLYSTYRENE SULFONATE;
sodium polystyrene sulfonate 1 g / g;
2018-10-25;
Oral , Rectal;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02473941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96396
JAMP SODIUM POLYSTYRENE SULFONATE;
sodium polystyrene sulfonate 1 g / g;
2021-02-04;
Oral , Rectal;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02497557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98738
SOLYSTAT;
sodium polystyrene sulfonate 250 mg / ml;
1989-12-31;
Oral;
Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00769541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9611
ODAN-SODIUM POLYSTYRENE SULFONATE;
sodium polystyrene sulfonate 250 mg / ml;
2018-12-11;
Oral , Rectal;
Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02473968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96397
TROMBOJECT 1% INJ 10MG/ML;
sodium tetradecyl sulfate 10 mg / ml;
1987-12-31;
Intravenous;
Solution;
24:16.00 – SCLEROSING AGENTS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 00511234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8275
TROMBOJECT 3% INJ 30MG/ML;
sodium tetradecyl sulfate 30 mg / ml;
1987-12-31;
Intravenous;
Solution;
24:16.00 – SCLEROSING AGENTS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 00511226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8274
SODIUM THIOSULFATE INJECTION USP;
sodium thiosulfate 250 mg / ml;
1998-07-13;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Ethical;
PFIZER CANADA ULC
DIN: 02137186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31283
SEACALPHYX;
sodium thiosulfate 250 mg / ml;
2013-01-08;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Ethical;
SEAFORD PHARMACEUTICALS INC
DIN: 02386666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87223
SODIUM THIOSULFATE INJECTION USP;
sodium thiosulfate 250 mg / ml;
2015-11-23;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Ethical;
HOPE PHARMACEUTICALS LTD
DIN: 02428393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91283
LOKELMA;
sodium zirconium cyclosilicate 10 g / sachet;
2019-10-17;
Oral;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02490722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98078
LOKELMA;
sodium zirconium cyclosilicate 5 g / sachet;
2019-10-17;
Oral;
Powder For Suspension;
40:18.18 – POTASSIUM-REMOVING AGENTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02490714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98077
SOVALDI;
sofosbuvir 400 mg;
2014-01-06;
Oral;
Tablet;
08:18.92 – MISCELLANEOUS ANTIVIRALS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02418355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90293
VESICARE;
solifenacin succinate 10 mg;
2006-06-23;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02277271
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76293
TEVA-SOLIFENACIN;
solifenacin succinate 10 mg;
2015-07-30;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
DIN: 02397919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88284
SANDOZ SOLIFENACIN;
solifenacin succinate 10 mg;
2015-09-30;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02399040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88395
PMS-SOLIFENACIN;
solifenacin succinate 10 mg;
2015-10-28;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMASCIENCE INC
DIN: 02417731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90236
JAMP-SOLIFENACIN;
solifenacin succinate 10 mg;
2015-12-29;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02424347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90905
TARO-SOLIFENACIN;
solifenacin succinate 10 mg;
2015-12-29;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SUN PHARMA CANADA INC
DIN: 02437996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92235
AURO-SOLIFENACIN;
solifenacin succinate 10 mg;
2016-01-04;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
AURO PHARMA INC
DIN: 02446383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93172
SOLIFENACIN;
solifenacin succinate 10 mg;
2016-10-27;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PRO DOC LIMITEE
DIN: 02458152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94520
SOLIFENACIN;
solifenacin succinate 10 mg;
2016-11-03;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SANIS HEALTH INC
DIN: 02458268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94536
PRZ-SOLIFENACIN;
solifenacin succinate 10 mg;
2020-11-13;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMARIS CANADA INC
DIN: 02493047
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98303
VESICARE;
solifenacin succinate 5 mg;
2006-06-23;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02277263
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76292
TEVA-SOLIFENACIN;
solifenacin succinate 5 mg;
2015-07-30;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
DIN: 02397900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88283
SANDOZ SOLIFENACIN;
solifenacin succinate 5 mg;
2015-09-30;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02399032
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88394
PMS-SOLIFENACIN;
solifenacin succinate 5 mg;
2015-10-28;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMASCIENCE INC
DIN: 02417723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90235
JAMP-SOLIFENACIN;
solifenacin succinate 5 mg;
2015-12-29;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02424339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90904
TARO-SOLIFENACIN;
solifenacin succinate 5 mg;
2015-12-29;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SUN PHARMA CANADA INC
DIN: 02437988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92234
AURO-SOLIFENACIN;
solifenacin succinate 5 mg;
2016-01-04;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
AURO PHARMA INC
DIN: 02446375
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93171
SOLIFENACIN;
solifenacin succinate 5 mg;
2016-10-27;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PRO DOC LIMITEE
DIN: 02458144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94519
SOLIFENACIN;
solifenacin succinate 5 mg;
2016-11-03;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SANIS HEALTH INC
DIN: 02458241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94535
PRZ-SOLIFENACIN;
solifenacin succinate 5 mg;
2020-11-13;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
PHARMARIS CANADA INC
DIN: 02493039
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98302
GENOTROPIN;
somatropin 0.2 mg / syr;
2020-09-17;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88662
GENOTROPIN;
somatropin 0.4 mg / syr;
2020-09-17;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88663
GENOTROPIN;
somatropin 0.6 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88664
GENOTROPIN;
somatropin 0.8 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88665
GENOTROPIN;
somatropin 1 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401789
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88666
GENOTROPIN;
somatropin 1.2 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401797
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88667
GENOTROPIN;
somatropin 1.4 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88668
GENOTROPIN;
somatropin 1.6 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88669
GENOTROPIN;
somatropin 1.8 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88670
OMNITROPE;
somatropin 10 mg / 1.5 ml;
2009-04-20;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
DIN: 02325071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81049
NORDITROPIN NORDIFLEX;
somatropin 10 mg / 1.5 ml;
2014-08-15;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02334860
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82049
NUTROPIN AQ NUSPIN 10;
somatropin 10 mg / 2 ml;
2012-05-18;
Subcutaneous;
Solution;
68:30.04 – SOMATOTROPIN AGONISTS*;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02376393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86186
GENOTROPIN;
somatropin 12 mg / pen;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401711
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88660
NORDITROPIN NORDIFLEX;
somatropin 15 mg / 1.5 ml;
2014-08-15;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02334879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82050
OMNITROPE;
somatropin 15 mg / 1.5 ml;
2017-08-14;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
DIN: 02459647
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94695
GENOTROPIN;
somatropin 2 mg / syr;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88671
NUTROPIN AQ NUSPIN 20;
somatropin 20 mg / 2 ml;
2013-09-09;
Subcutaneous;
Solution;
68:30.04 – SOMATOTROPIN AGONISTS*;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02399083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88398
SAIZEN;
somatropin 5 mg / vial;
1999-10-26;
Intramuscular , Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02237971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61332
OMNITROPE;
somatropin 5 mg / 1.5 ml;
2009-04-20;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
DIN: 02325063
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81048
NORDITROPIN NORDIFLEX;
somatropin 5 mg / 1.5 ml;
2014-08-15;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02334852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82048
NUTROPIN AQ NUSPIN 5;
somatropin 5 mg / 2 ml;
2013-09-09;
Subcutaneous;
Solution;
68:30.04 – SOMATOTROPIN AGONISTS*;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02399091
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88400
GENOTROPIN;
somatropin 5.3 mg / pen;
2013-09-18;
Subcutaneous;
Powder For Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02401703
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88659
SAIZEN;
somatropin 5.83 mg / ml;
2010-12-02;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02350122
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83536
SAIZEN;
somatropin 8 mg / ml;
2010-12-02;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02350130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83537
SAIZEN;
somatropin 8 mg / ml;
2010-12-02;
Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02350149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83538
ODOMZO;
sonidegib (sonidegib phosphate) 200 mg;
2020-12-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SUN PHARMA GLOBAL FZE
DIN: 02500337
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99003
NEXAVAR;
sorafenib (sorafenib tosylate) 200 mg;
2006-07-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAYER INC
DIN: 02284227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76977
APO-SOTALOL – TAB 160MG;
sotalol hydrochloride 160 mg;
1995-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 02167794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18779
PMS-SOTALOL – 160 MG;
sotalol hydrochloride 160 mg;
1998-07-22;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02238327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61730
RIVA-SOTALOL;
sotalol hydrochloride 160 mg;
2016-07-15;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02272172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75770
JAMP-SOTALOL;
sotalol hydrochloride 160 mg;
2011-10-20;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02368625
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85360
APO-SOTALOL 80MG TABLETS;
sotalol hydrochloride 80 mg;
1996-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 02210428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20002
PMS-SOTALOL – 80 MG;
sotalol hydrochloride 80 mg;
1998-07-22;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02238326
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61729
JAMP-SOTALOL;
sotalol hydrochloride 80 mg;
2011-10-20;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02368617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85359
INTRALIPID 20%;
soybean oil 20 % / w/v;
1995-12-31;
Intravenous;
Emulsion;
40:20.00 – CALORIC AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02065673
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18647
ROVAMYCINE 500 CAPSULE 1500000 UNIT;
spiramycin 1500000 unit;
1957-12-31;
Oral;
Capsule;
08:12.12 – MACROLIDES;
Prescription;
ODAN LABORATORIES LTD
DIN: 01927817
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12601
ROVAMYCINE 250 CAPSULE 750000 UNIT;
spiramycin 750000 unit;
1957-12-31;
Oral;
Capsule;
08:12.12 – MACROLIDES;
Prescription;
ODAN LABORATORIES LTD
DIN: 01927825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13090
ALDACTONE 100 MG;
spironolactone 100 mg;
1975-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
PFIZER CANADA ULC
DIN: 00285455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2145
TEVA-SPIRONOLACTONE;
spironolactone 100 mg;
1984-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00613223
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5647
MINT-SPIRONOLACTONE;
spironolactone 100 mg;
2020-02-06;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02488159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97826
ALDACTONE 25 MG;
spironolactone 25 mg;
1959-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
PFIZER CANADA ULC
DIN: 00028606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1403
TEVA-SPIRONOLACTONE;
spironolactone 25 mg;
1984-12-31;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00613215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5646
MINT-SPIRONOLACTONE;
spironolactone 25 mg;
2020-02-06;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02488140
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97825
ITULATEK;
standardized allergen extract – white birch (betula verrucosa) 12 unit;
2020-09-28;
Sublingual;
Tablet;
92:05.00* – ALLERGENIC EXTRACTS;
Prescription , Schedule D;
ALK-ABELLO A/S
DIN: 02498073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98787
STANDARDIZED CAT HAIR AP;
standardized cat hair acetone precipitated 10000 unit / ml;
1998-08-28;
Intradermal , Subcutaneous;
Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
DIN: 02217457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43218
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – KENTUCKY BLUE/JUNE;
standardized kentucky blue/june grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02242666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66455
ALLERGENIC EXTRACT – STANDARDIZED JUNE GRASS POLLEN;
standardized kentucky blue/june grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 02325454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81083
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – MEADOW FESCUE;
standardized meadow fescue grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02242672
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66461
ALLERGENIC EXTRACT – STANDARDIZED MEADOW FESCUE GRASS POLLEN;
standardized meadow fescue grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 02325527
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81090
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – ORCHARD;
standardized orchard grass pollen 100000 unit / ml;
2000-10-31;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02242674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66463
ALLERGENIC EXTRACT – STANDARDIZED ORCHARD GRASS POLLEN;
standardized orchard grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 02325489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81086
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – PERENNIAL RYE;
standardized perennial rye grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02242676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66465
ALLERGENIC EXTRACT – STANDARDIZED PERENNNIAL RYE GRASS POLLEN;
standardized perennial rye grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 02325500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81088
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – RED TOP;
standardized redtop grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02242670
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66459
ALLERGENIC EXTRACT – STANDARDIZED REDTOP GRASS POLLEN;
standardized redtop grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 02325497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81087
RAGWITEK;
standardized short ragweed pollen allergenic extract 12 unit;
2014-04-29;
Sublingual;
Tablet (Orally Disintegrating);
92:05.00* – ALLERGENIC EXTRACTS;
Prescription , Schedule D;
ALK-ABELLO A/S
DIN: 02423723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90842
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – SWEET VERNAL;
standardized sweet vernal grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02242668
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66457
ALLERGENIC EXTRACT – STANDARDIZED SWEET VERNAL GRASS POLLEN;
standardized sweet vernal grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 02325519
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81089
ALLERGENIC EXTRACT – STANDARDIZED GRASS POLLEN – TIMOTHY;
standardized timothy grass pollen 100000 unit / ml;
2000-10-30;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02242664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66453
ALLERGENIC EXTRACT – STANDARDIZED TIMOTHY GRASS POLLEN;
standardized timothy grass pollen 100000 unit / ml;
2009-07-30;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 02325470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81085
GRASTEK;
standardized timothy grass pollen 2800 unit;
2014-01-14;
Sublingual;
Tablet (Orally Disintegrating);
92:05.00* – ALLERGENIC EXTRACTS;
Prescription , Schedule D;
ALK-ABELLO A/S
DIN: 02418304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90288
DIACOMIT;
stiripentol 250 mg;
2013-05-01;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOCODEX SAS
DIN: 02398958
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88386
DIACOMIT;
stiripentol 250 mg / sachet;
2013-05-01;
Oral;
Powder For Suspension;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOCODEX SAS
DIN: 02398974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88388
DIACOMIT;
stiripentol 500 mg;
2013-05-01;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOCODEX SAS
DIN: 02398966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88387
STREPTOMYCIN FOR INJECTION USP;
streptomycin (streptomycin sulfate) 1 g / vial;
2001-10-15;
Intramuscular;
Powder For Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
STERIMAX INC
DIN: 02243660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67590
QUELICIN;
succinylcholine chloride 20 mg / ml;
1952-12-31;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 00038172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=227
SUCCINYLCHOLINE CHLORIDE INJECTION USP;
succinylcholine chloride 20 mg / ml;
2014-09-30;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02422336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90702
SUCCINYLCHOLINE CHLORIDE INJECTION, USP;
succinylcholine chloride 20 mg / ml;
2020-09-29;
Intravenous;
Solution;
12:20.20 – NEUROMUSCULAR BLOCKING AGENTS;
Prescription;
DR REDDY’S LABORATORIES LTD
DIN: 02501783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99139
TEVA-SUCRALFATE;
sucralfate 1 g;
1993-12-31;
Oral;
Tablet;
56:28.32 – PROTECTANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02045702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14504
APO-SUCRALFATE – TAB 1G;
sucralfate 1 g;
1994-12-31;
Oral;
Tablet;
56:28.32 – PROTECTANTS;
Prescription;
APOTEX INC
DIN: 02125250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16656
SULCRATE;
sucralfate 1 g;
1995-12-31;
Oral;
Tablet;
56:28.32 – PROTECTANTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02100622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17250
SULCRATE SUSPENSION PLUS;
sucralfate 1 g / 5 ml;
1995-12-31;
Oral;
Suspension;
56:28.32 – PROTECTANTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02103567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17852
SUFENTANIL CITRATE INJECTION USP;
sufentanil (sufentanil citrate) 50 mcg / ml;
2001-08-01;
Intravenous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02244147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68108
SUFENTANIL CITRATE INJECTION USP;
sufentanil (sufentanil citrate) 50 mcg / ml;
2016-10-18;
Intravenous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
DIN: 02442213
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92657
BRIDION;
sugammadex (sugammadex sodium) 100 mg / ml;
2016-02-19;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Prescription;
MERCK CANADA INC
DIN: 02451816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93817
PMS-SULFASALAZINE 500MG/TAB USP;
sulfasalazine 500 mg;
1984-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
PHARMASCIENCE INC
DIN: 00598461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5728
PMS-SULFASALAZINE-E.C. TAB 500MG;
sulfasalazine 500 mg;
1984-12-31;
Oral;
Tablet (Enteric-Coated);
08:12.20 – SULFONAMIDES;
Prescription;
PHARMASCIENCE INC
DIN: 00598488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5864
SALAZOPYRIN TAB 500MG;
sulfasalazine 500 mg;
1995-12-31;
Oral;
Tablet;
08:12.20 – SULFONAMIDES;
Prescription;
PFIZER CANADA ULC
DIN: 02064480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17416
SALAZOPYRIN EN-TABS 500 MG;
sulfasalazine 500 mg;
1995-12-31;
Oral;
Tablet (Enteric-Coated);
08:12.20 – SULFONAMIDES;
Prescription;
PFIZER CANADA ULC
DIN: 02064472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17417
SONOVUE;
sulfur hexafluoride 8 mcl / ml;
2016-09-22;
Intravenous , Intravesical;
Powder For Suspension;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
BRACCO IMAGING CANADA
DIN: 02287684
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77308
TEVA-SULINDAC;
sulindac 150 mg;
1988-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00745588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9238
TEVA-SULINDAC;
sulindac 200 mg;
1988-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00745596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9239
IMITREX NASAL SPRAY;
sumatriptan (sumatriptan hemisulfate) 20 mg / act;
1997-02-19;
Nasal;
Spray;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02230420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49290
IMITREX NASAL SPRAY;
sumatriptan (sumatriptan hemisulfate) 5 mg / act;
1997-02-19;
Nasal;
Spray;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02230418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49288
IMITREX DF – TAB 100MG;
sumatriptan (sumatriptan succinate) 100 mg;
1997-02-11;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02212161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43077
TEVA-SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 100 mg;
2005-09-30;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02239367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62836
PMS-SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 100 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02256444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74165
ACT SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 100 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02257904
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74313
SANDOZ SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 100 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02263033
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74844
APO-SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 100 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
DIN: 02268396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75378
MYLAN-SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 100 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02268922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75432
SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 100 mg;
2010-04-05;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02286548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77199
TEVA-SUMATRIPTAN DF;
sumatriptan (sumatriptan succinate) 100 mg;
2006-10-30;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02286831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77229
SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 100 mg;
2009-06-15;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02324660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81010
SUMATRIPTAN DF;
sumatriptan (sumatriptan succinate) 100 mg;
2012-06-10;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87119
PMS-SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 25 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02256428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74163
MYLAN-SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 25 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02268906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75430
TEVA-SUMATRIPTAN DF;
sumatriptan (sumatriptan succinate) 25 mg;
2006-10-30;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02286815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77227
IMITREX DF – TAB 50MG;
sumatriptan (sumatriptan succinate) 50 mg;
1998-02-11;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02212153
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43076
PMS-SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 50 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02256436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74164
SANDOZ SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 50 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02263025
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74843
APO-SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 50 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
DIN: 02268388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75377
MYLAN-SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 50 mg;
2005-08-24;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02268914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75431
SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 50 mg;
2010-04-05;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02286521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77198
TEVA-SUMATRIPTAN DF;
sumatriptan (sumatriptan succinate) 50 mg;
2006-10-30;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02286823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77228
SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 50 mg;
2009-06-15;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02324652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81009
SUMATRIPTAN DF;
sumatriptan (sumatriptan succinate) 50 mg;
2012-06-10;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87118
IMITREX;
sumatriptan (sumatriptan succinate) 6 mg / 0.5 ml;
1999-08-30;
Subcutaneous;
Liquid;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02212188
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43078
TARO-SUMATRIPTAN;
sumatriptan (sumatriptan succinate) 6 mg / 0.5 ml;
2011-06-06;
Subcutaneous;
Solution;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02361698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84675
SUTENT;
sunitinib (sunitinib malate) 12.5 mg;
2006-06-22;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02280795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76647
SUTENT;
sunitinib (sunitinib malate) 25 mg;
2006-06-22;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02280809
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76648
SUTENT;
sunitinib (sunitinib malate) 50 mg;
2006-06-22;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02280817
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76649
SANDOZ TACROLIMUS;
tacrolimus (tacrolimus monohydrate) 0.5 mg;
2014-06-11;
Oral;
Capsule (Immediate Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02416816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90142
SANDOZ TACROLIMUS;
tacrolimus (tacrolimus monohydrate) 1 mg;
2013-11-25;
Oral;
Capsule (Immediate Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02416824
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90143
SANDOZ TACROLIMUS;
tacrolimus (tacrolimus monohydrate) 5 mg;
2013-11-25;
Oral;
Capsule (Immediate Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02416832
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90144
PROTOPIC;
tacrolimus 0.03 % / w/w;
2001-09-06;
Topical;
Ointment;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
DIN: 02244149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68110
PROTOPIC;
tacrolimus 0.1 % / w/w;
2001-09-06;
Topical;
Ointment;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
LEO PHARMA INC
DIN: 02244148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68109
PROGRAF;
tacrolimus 0.5 mg;
2001-04-02;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02243144
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67015
ADVAGRAF;
tacrolimus 0.5 mg;
2008-04-09;
Oral;
Capsule (Extended Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02296462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78179
ENVARSUS PA;
tacrolimus 0.75 mg;
2019-04-17;
Oral;
Tablet (Extended-Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ENDO VENTURES LTD.
DIN: 02485877
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97609
PROGRAF;
tacrolimus 1 mg;
1996-08-14;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02175991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44211
ADVAGRAF;
tacrolimus 1 mg;
2008-04-09;
Oral;
Capsule (Extended Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02296470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78180
ENVARSUS PA;
tacrolimus 1 mg;
2019-04-17;
Oral;
Tablet (Extended-Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ENDO VENTURES LTD.
DIN: 02485885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97610
ADVAGRAF;
tacrolimus 3 mg;
2010-04-05;
Oral;
Capsule (Extended Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02331667
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81736
ENVARSUS PA;
tacrolimus 4 mg;
2019-04-17;
Oral;
Tablet (Extended-Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ENDO VENTURES LTD.
DIN: 02485893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97611
PROGRAF;
tacrolimus 5 mg;
1996-08-14;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02175983
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44210
ADVAGRAF;
tacrolimus 5 mg;
2008-04-09;
Oral;
Capsule (Extended Release);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02296489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78181
PROGRAF;
tacrolimus 5 mg / ml;
1996-08-14;
Intravenous;
Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02176009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44212
CIALIS;
tadalafil 10 mg;
2003-12-11;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ELI LILLY CANADA INC
DIN: 02248088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72410
PMS-TADALAFIL;
tadalafil 10 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02409437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89414
MYLAN-TADALAFIL;
tadalafil 10 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02410656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89532
APO-TADALAFIL;
tadalafil 10 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02422107
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90682
AURO-TADALAFIL;
tadalafil 10 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02435934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92027
TEVA-TADALAFIL;
tadalafil 10 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02440164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92454
JAMP-TADALAFIL;
tadalafil 10 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02451840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93820
MAR-TADALAFIL;
tadalafil 10 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02452251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93849
RAN-TADALAFIL;
tadalafil 10 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02452103
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93853
PRIVA-TADALAFIL;
tadalafil 10 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02452499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93887
TADALAFIL;
tadalafil 10 mg;
2016-09-09;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02455366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94217
CIALIS;
tadalafil 2.5 mg;
2008-01-18;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ELI LILLY CANADA INC
DIN: 02296888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78223
PMS-TADALAFIL;
tadalafil 2.5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02409410
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89412
MYLAN-TADALAFIL;
tadalafil 2.5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02410621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89530
APO-TADALAFIL;
tadalafil 2.5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02422085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90680
AURO-TADALAFIL;
tadalafil 2.5 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02435896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92025
TEVA-TADALAFIL;
tadalafil 2.5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02440148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92452
RAN-TADALAFIL;
tadalafil 2.5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02452081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93852
CIALIS;
tadalafil 20 mg;
2003-11-25;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ELI LILLY CANADA INC
DIN: 02248089
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72411
ADCIRCA;
tadalafil 20 mg;
2010-01-19;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ELI LILLY CANADA INC
DIN: 02338327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82395
PMS-TADALAFIL;
tadalafil 20 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02409445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89415
MYLAN-TADALAFIL;
tadalafil 20 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02410664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89533
APO-TADALAFIL PAH;
tadalafil 20 mg;
2015-10-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02421933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90663
APO-TADALAFIL;
tadalafil 20 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02422115
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90683
AURO-TADALAFIL;
tadalafil 20 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02435942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92028
TEVA-TADALAFIL;
tadalafil 20 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02440172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92455
MINT-TADALAFIL;
tadalafil 20 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02451697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93793
JAMP-TADALAFIL;
tadalafil 20 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02451859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93821
MAR-TADALAFIL;
tadalafil 20 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02452243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93850
RAN-TADALAFIL;
tadalafil 20 mg;
2016-07-15;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02452111
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93854
PRIVA-TADALAFIL;
tadalafil 20 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02452502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93888
RIVA-TADALAFIL;
tadalafil 20 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02454742
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94143
TADALAFIL;
tadalafil 20 mg;
2016-08-11;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02455374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94218
AG-TADALAFIL;
tadalafil 20 mg;
2019-11-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ANGITA PHARMA INC.
DIN: 02481421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97175
CIALIS;
tadalafil 5 mg;
2008-01-18;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
ELI LILLY CANADA INC
DIN: 02296896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78224
PMS-TADALAFIL;
tadalafil 5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02409429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89413
MYLAN-TADALAFIL;
tadalafil 5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02410648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89531
APO-TADALAFIL;
tadalafil 5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02422093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90681
AURO-TADALAFIL;
tadalafil 5 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02435926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92026
TEVA-TADALAFIL;
tadalafil 5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02440156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92453
MINT-TADALAFIL;
tadalafil 5 mg;
2016-07-14;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02451670
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93791
JAMP-TADALAFIL;
tadalafil 5 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02451832
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93819
MAR-TADALAFIL;
tadalafil 5 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02452278
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93848
RAN-TADALAFIL;
tadalafil 5 mg;
2016-07-12;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02452073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93851
PRIVA-TADALAFIL;
tadalafil 5 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PHARMAPAR INC
DIN: 02452480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93886
RIVA-TADALAFIL;
tadalafil 5 mg;
2016-07-13;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02454726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94141
TADALAFIL;
tadalafil 5 mg;
2016-08-11;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02455358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94216
VYNDAQEL;
tafamidis meglumine 20 mg;
2020-04-07;
Oral;
Capsule;
24:04.92 – MISCELLANEOUS CARDIAC DRUGS;
Prescription;
PFIZER CANADA ULC
DIN: 02495732
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98563
ELELYSO;
taliglucerase alfa 200 unit / vial;
2014-09-08;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02425637
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91027
APO-TAMOX TAB 10MG;
tamoxifen (tamoxifen citrate) 10 mg;
1989-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
DIN: 00812404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10664
TEVA-TAMOXIFEN;
tamoxifen (tamoxifen citrate) 10 mg;
1990-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00851965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10790
APO-TAMOX TAB 20MG;
tamoxifen (tamoxifen citrate) 20 mg;
1989-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
DIN: 00812390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10762
TEVA-TAMOXIFEN;
tamoxifen (tamoxifen citrate) 20 mg;
1990-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00851973
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10791
NOLVADEX-D TAB 20MG;
tamoxifen (tamoxifen citrate) 20 mg;
1995-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02048485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18639
FLOMAX CR;
tamsulosin hydrochloride 0.4 mg;
2005-10-11;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02270102
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75550
SANDOZ TAMSULOSIN;
tamsulosin hydrochloride 0.4 mg;
2014-03-19;
Oral;
Capsule (Sustained-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02319217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80468
SANDOZ TAMSULOSIN CR;
tamsulosin hydrochloride 0.4 mg;
2011-01-04;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02340208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82577
APO-TAMSULOSIN CR;
tamsulosin hydrochloride 0.4 mg;
2012-02-09;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
APOTEX INC
DIN: 02362406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84741
TEVA-TAMSULOSIN CR;
tamsulosin hydrochloride 0.4 mg;
2013-09-04;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
TEVA CANADA LIMITED
DIN: 02368242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85321
TAMSULOSIN CR;
tamsulosin hydrochloride 0.4 mg;
2013-11-21;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
PRO DOC LIMITEE
DIN: 02413612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89826
TAMSULOSIN CR;
tamsulosin hydrochloride 0.4 mg;
2014-07-24;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SANIS HEALTH INC
DIN: 02427117
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91164
TAMSULOSIN CR;
tamsulosin hydrochloride 0.4 mg;
2014-10-08;
Oral;
Tablet (Extended-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02429667
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91411
RATIO-TAMSULOSIN;
tamsulosin hydrochloride 0.4 mg / cap;
2007-04-27;
Oral;
Capsule (Sustained-Release);
12:16.04.12 – Selective Alfa-1-Adrenergic Blocking Agents;
Prescription;
TEVA CANADA LIMITED
DIN: 02294265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77961
NUCYNTA IR;
tapentadol (tapentadol hydrochloride) 100 mg;
2012-03-20;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
DIN: 02378299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86411
NUCYNTA EXTENDED-RELEASE;
tapentadol (tapentadol hydrochloride) 100 mg;
2014-04-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
DIN: 02415585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90017
NUCYNTA EXTENDED-RELEASE;
tapentadol (tapentadol hydrochloride) 150 mg;
2014-04-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
DIN: 02415593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90018
NUCYNTA EXTENDED-RELEASE;
tapentadol (tapentadol hydrochloride) 200 mg;
2014-04-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
DIN: 02415607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90019
NUCYNTA EXTENDED-RELEASE;
tapentadol (tapentadol hydrochloride) 250 mg;
2014-04-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
DIN: 02415615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90020
NUCYNTA IR;
tapentadol (tapentadol hydrochloride) 50 mg;
2012-03-20;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
DIN: 02378272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86409
NUCYNTA EXTENDED-RELEASE;
tapentadol (tapentadol hydrochloride) 50 mg;
2014-04-16;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
DIN: 02415577
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90016
NUCYNTA IR;
tapentadol (tapentadol hydrochloride) 75 mg;
2012-03-20;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ENDO VENTURES LTD.
DIN: 02378280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86410
TAZORAC;
tazarotene 0.05 %;
1997-04-10;
Topical;
Gel;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ALLERGAN INC
DIN: 02230784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50053
TAZORAC;
tazarotene 0.05 %;
2001-08-31;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ALLERGAN INC
DIN: 02243894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67835
TAZORAC;
tazarotene 0.1 %;
1997-04-10;
Topical;
Gel;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ALLERGAN INC
DIN: 02230785
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50054
TAZORAC;
tazarotene 0.1 %;
2001-08-31;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ALLERGAN INC
DIN: 02243895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67836
REVESTIVE;
teduglutide 5 mg / vial;
2015-10-28;
Subcutaneous;
Kit , Powder For Solution;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription , Schedule D;
TAKEDA CANADA INC
DIN: 02445727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93100
MICARDIS 40MG TAB;
telmisartan 40 mg;
1999-09-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02240769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64358
TEVA-TELMISARTAN;
telmisartan 40 mg;
2012-01-09;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02320177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80562
SANDOZ TELMISARTAN;
telmisartan 40 mg;
2012-01-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02375958
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86141
JAMP TELMISARTAN;
telmisartan 40 mg;
2020-12-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02386755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87235
TELMISARTAN;
telmisartan 40 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02388944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87447
TELMISARTAN;
telmisartan 40 mg;
2012-07-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02390345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87579
TELMISARTAN;
telmisartan 40 mg;
2012-11-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02395223
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88034
ACH-TELMISARTAN;
telmisartan 40 mg;
2014-03-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02407485
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89217
AURO-TELMISARTAN;
telmisartan 40 mg;
2016-04-08;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02453568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94012
MINT-TELMISARTAN;
telmisartan 40 mg;
2020-04-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02486369
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97657
PMS-TELMISARTAN;
telmisartan 40 mg;
2021-03-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02499622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98935
MICARDIS 80MG TAB;
telmisartan 80 mg;
1999-09-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02240770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64359
TEVA-TELMISARTAN;
telmisartan 80 mg;
2012-01-09;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02320185
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80563
SANDOZ TELMISARTAN;
telmisartan 80 mg;
2012-01-04;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02375966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86142
JAMP TELMISARTAN;
telmisartan 80 mg;
2020-12-29;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02386763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87236
TELMISARTAN;
telmisartan 80 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02388952
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87448
TELMISARTAN;
telmisartan 80 mg;
2012-07-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02390353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87580
TELMISARTAN;
telmisartan 80 mg;
2012-11-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02395231
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88035
ACH-TELMISARTAN;
telmisartan 80 mg;
2014-03-12;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02407493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89218
AURO-TELMISARTAN;
telmisartan 80 mg;
2016-04-08;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02453576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94013
MINT-TELMISARTAN;
telmisartan 80 mg;
2020-03-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02486377
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97658
PMS-TELMISARTAN;
telmisartan 80 mg;
2021-03-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02499630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98936
XERMELO;
telotristat ethyl (telotristat etiprate) 250 mg;
2018-12-07;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Prescription;
IPSEN BIOPHARMACEUTICALS CANADA INC
DIN: 02481553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97200
RESTORIL;
temazepam 15 mg;
1980-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
DIN: 00604453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5616
RESTORIL;
temazepam 30 mg;
1980-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
DIN: 00604461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5618
TEMODAL;
temozolomide 100 mg;
1999-11-12;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
DIN: 02241095
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64698
ACH-TEMOZOLOMIDE;
temozolomide 100 mg;
2012-07-25;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02389827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87530
ACT TEMOZOLOMIDE;
temozolomide 100 mg;
2012-11-07;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88039
TARO-TEMOZOLOMIDE;
temozolomide 100 mg;
2015-07-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02443511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92820
TEMODAL;
temozolomide 140 mg;
2009-02-21;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
DIN: 02312794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79831
ACH-TEMOZOLOMIDE;
temozolomide 140 mg;
2012-07-25;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02389835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87531
ACT TEMOZOLOMIDE;
temozolomide 140 mg;
2012-11-07;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88040
TARO-TEMOZOLOMIDE;
temozolomide 140 mg;
2015-07-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02443538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92821
TEMODAL;
temozolomide 20 mg;
1999-11-12;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
DIN: 02241094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64697
ACH-TEMOZOLOMIDE;
temozolomide 20 mg;
2012-07-25;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02389819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87529
ACT TEMOZOLOMIDE;
temozolomide 20 mg;
2012-11-07;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88038
TARO-TEMOZOLOMIDE;
temozolomide 20 mg;
2015-07-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02443481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92818
TEMODAL;
temozolomide 250 mg;
1999-11-12;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
DIN: 02241096
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64699
ACH-TEMOZOLOMIDE;
temozolomide 250 mg;
2012-07-25;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02389851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87533
ACT TEMOZOLOMIDE;
temozolomide 250 mg;
2012-11-07;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02395312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88042
TARO-TEMOZOLOMIDE;
temozolomide 250 mg;
2015-07-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02443554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92823
TEMODAL;
temozolomide 5 mg;
1999-11-12;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
DIN: 02241093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64696
ACH-TEMOZOLOMIDE;
temozolomide 5 mg;
2016-01-13;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02438119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92249
ACT TEMOZOLOMIDE;
temozolomide 5 mg;
2015-12-08;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02441160
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92553
TARO-TEMOZOLOMIDE;
temozolomide 5 mg;
2015-07-23;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02443473
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92817
TORISEL;
temsirolimus 25 mg / ml;
2008-01-11;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02304104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78941
IBSRELA;
tenapanor (tenapanor hydrochloride) 50 mg;
2020-11-23;
Oral;
Tablet;
-;
Prescription;
KNIGHT THERAPEUTICS INC.
DIN: 02498049
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98784
TNKASE;
tenecteplase 50 mg / vial;
2001-10-18;
Intravenous;
Powder For Solution;
20:12.20 – THROMBOLYTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02244826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68816
VEMLIDY;
tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg;
2017-06-20;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02464241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95241
VIREAD;
tenofovir disoproxil fumarate 300 mg;
2004-03-15;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02247128
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71368
TEVA-TENOFOVIR;
tenofovir disoproxil fumarate 300 mg;
2017-07-26;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02403889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88865
APO-TENOFOVIR;
tenofovir disoproxil fumarate 300 mg;
2017-07-26;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02451980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93838
MYLAN-TENOFOVIR DISOPROXIL;
tenofovir disoproxil fumarate 300 mg;
2017-07-31;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02452634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93899
PMS-TENOFOVIR;
tenofovir disoproxil fumarate 300 mg;
2018-04-25;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02453940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94047
AURO-TENOFOVIR;
tenofovir disoproxil fumarate 300 mg;
2017-07-26;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02460173
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94747
NAT-TENOFOVIR;
tenofovir disoproxil fumarate 300 mg;
2018-03-15;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02472511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96182
JAMP-TENOFOVIR;
tenofovir disoproxil fumarate 300 mg;
2018-10-24;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02479087
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96979
RIVA-TENOFOVIR;
tenofovir disoproxil fumarate 300 mg;
2021-06-14;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02515156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100454
APO-TERAZOSIN;
terazosin (terazosin hydrochloride) 1 mg;
1997-09-26;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 02234502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55839
PMS-TERAZOSIN;
terazosin (terazosin hydrochloride) 1 mg;
2001-02-23;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02243518
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67437
TERAZOSIN;
terazosin (terazosin hydrochloride) 1 mg;
2010-05-12;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83568
APO-TERAZOSIN;
terazosin (terazosin hydrochloride) 10 mg;
1997-09-26;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 02234505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55842
PMS-TERAZOSIN;
terazosin (terazosin hydrochloride) 10 mg;
2001-02-23;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02243521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67440
TERAZOSIN;
terazosin (terazosin hydrochloride) 10 mg;
2010-05-12;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83571
APO-TERAZOSIN;
terazosin (terazosin hydrochloride) 2 mg;
1997-09-26;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 02234503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55840
TERAZOSIN-2;
terazosin (terazosin hydrochloride) 2 mg;
1998-06-02;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02237477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60811
PMS-TERAZOSIN;
terazosin (terazosin hydrochloride) 2 mg;
2001-02-23;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02243519
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67438
TERAZOSIN;
terazosin (terazosin hydrochloride) 2 mg;
2010-05-12;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83569
TEVA-TERAZOSIN;
terazosin (terazosin hydrochloride) 5 mg;
1998-02-09;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02230807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50071
APO-TERAZOSIN;
terazosin (terazosin hydrochloride) 5 mg;
1997-09-26;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 02234504
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55841
TERAZOSIN-5;
terazosin (terazosin hydrochloride) 5 mg;
1998-06-02;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02237478
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60812
PMS-TERAZOSIN;
terazosin (terazosin hydrochloride) 5 mg;
2001-02-23;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02243520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67439
TERAZOSIN;
terazosin (terazosin hydrochloride) 5 mg;
2010-05-12;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83570
LAMISIL TAB 250MG;
terbinafine (terbinafine hydrochloride) 250 mg;
1993-12-31;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02031116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13990
APO-TERBINAFINE;
terbinafine (terbinafine hydrochloride) 250 mg;
2000-05-16;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
APOTEX INC
DIN: 02239893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63385
TERBINAFINE-250;
terbinafine (terbinafine hydrochloride) 250 mg;
2008-03-07;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
PRO DOC LIMITEE
DIN: 02242735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66543
ACT TERBINAFINE;
terbinafine (terbinafine hydrochloride) 250 mg;
2005-02-11;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
TEVA CANADA LIMITED
DIN: 02254727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73989
RIVA-TERBINAFINE;
terbinafine (terbinafine hydrochloride) 250 mg;
2005-02-10;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02262924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74833
PMS-TERBINAFINE;
terbinafine (terbinafine hydrochloride) 250 mg;
2009-06-19;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
PHARMASCIENCE INC
DIN: 02294273
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77963
AURO-TERBINAFINE;
terbinafine (terbinafine hydrochloride) 250 mg;
2011-05-30;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
AURO PHARMA INC
DIN: 02320134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80558
TERBINAFINE;
terbinafine (terbinafine hydrochloride) 250 mg;
2010-07-26;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
SANIS HEALTH INC
DIN: 02353121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83835
TERBINAFINE;
terbinafine (terbinafine hydrochloride) 250 mg;
2012-06-10;
Oral;
Tablet;
08:14.04 – ALLYLAMINES;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87091
LAMISIL CRM 1%;
terbinafine hydrochloride 1 %;
1993-12-31;
Topical;
Cream;
84:04.08.04 – ALLYLAMINES;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02031094
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14532
LAMISIL;
terbinafine hydrochloride 1 % / w/w;
1999-01-05;
Topical;
Spray;
84:04.08.04 – ALLYLAMINES;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02238703
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62135
BRICANYL TURBUHALER;
terbutaline sulfate 0.5 mg / act;
1990-12-31;
Inhalation;
Powder (Metered Dose);
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 00786616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10665
TARO-TERCONAZOLE CREAM;
terconazole 0.4 %;
2004-09-21;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02247651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71914
AUBAGIO;
teriflunomide 14 mg;
2013-11-15;
Oral;
Tablet;
92:20.00 – Immunomodulatory Agents;
Prescription;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN: 02416328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90088
TEVA-TERIPARATIDE INJECTION;
teriparatide (teriparatide acetate) 250 mcg / ml;
2020-07-08;
Subcutaneous;
Solution;
68:24.08 – PARATHYROID AGENTS , 92:22.00 – BONE ANABOLIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02486423
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97663
FORTEO;
teriparatide 250 mcg / ml;
2004-07-15;
Subcutaneous;
Solution;
68:24.08 – PARATHYROID AGENTS , 92:22.00 – BONE ANABOLIC AGENTS;
Prescription , Schedule D;
ELI LILLY CANADA INC
DIN: 02254689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73983
OSNUVO;
teriparatide 250 mcg / ml;
2020-10-27;
Subcutaneous;
Solution;
68:24.08 – PARATHYROID AGENTS , 92:22.00 – BONE ANABOLIC AGENTS;
Prescription , Schedule D;
AVIR PHARMA INC.
DIN: 02495589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98548
EGRIFTA;
tesamorelin (tesamorelin acetate) 1 mg / vial;
2015-06-23;
Subcutaneous;
Kit , Powder For Solution;
68:30.04 – SOMATOTROPIN AGONISTS*;
Prescription;
THERATECHNOLOGIES INC
DIN: 02438712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92311
ANDROGEL;
testosterone 1 %;
2002-05-06;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
BGP PHARMA ULC
DIN: 02245345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69384
ANDROGEL;
testosterone 1 %;
2002-05-06;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
BGP PHARMA ULC
DIN: 02245346
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69385
TESTIM 1%;
testosterone 1 %;
2007-04-17;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
PALADIN LABS INC.
DIN: 02280248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76591
TARO-TESTOSTERONE GEL;
testosterone 1 %;
2017-10-31;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
TARO PHARMACEUTICALS INC
DIN: 02463792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95189
TARO-TESTOSTERONE GEL;
testosterone 1 %;
2017-10-31;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
TARO PHARMACEUTICALS INC
DIN: 02463806
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95190
ANDROGEL;
testosterone 12.5 mg / act;
2004-09-20;
Transdermal;
Gel;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
BGP PHARMA ULC
DIN: 02249499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73432
ANDRODERM;
testosterone 2.5 mg / 24 hour;
2000-12-19;
Transdermal;
Patch;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
ALLERGAN INC
DIN: 02239653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63125
ANDRODERM;
testosterone 5 mg / 24 hour;
2002-09-24;
Transdermal;
Patch;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
ALLERGAN INC
DIN: 02245972
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70098
DEPO-TESTOSTERONE INJ 100MG/ML;
testosterone cypionate 100 mg / ml;
1953-12-31;
Intramuscular;
Solution;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
PFIZER CANADA ULC
DIN: 00030783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1398
TARO-TESTOSTERONE CYPIONATE INJECTION;
testosterone cypionate 100 mg / ml;
2020-10-20;
Intramuscular;
Solution;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
TARO PHARMACEUTICALS INC
DIN: 02496003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98589
DELATESTRYL;
testosterone enanthate 200 mg / ml;
1955-12-31;
Intramuscular;
Solution;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
BAUSCH HEALTH, CANADA INC.
DIN: 00029246
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1275
PMS-TESTOSTERONE;
testosterone undecanoate 40 mg;
2009-10-08;
Oral;
Capsule;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
PHARMASCIENCE INC
DIN: 02322498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80793
TARO-TESTOSTERONE;
testosterone undecanoate 40 mg;
2014-09-02;
Oral;
Capsule;
68:08.00 – ANDROGENS;
Schedule G (Cdsa Iv);
TARO PHARMACEUTICALS INC
DIN: 02421186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90578
HYPERTET S/D;
tetanus immunoglobulin (human) 250 unit / dose;
1997-07-08;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
GRIFOLS THERAPEUTICS LLC
DIN: 02230697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49957
NITOMAN;
tetrabenazine 25 mg;
1996-12-09;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02199270
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42959
PMS-TETRABENAZINE;
tetrabenazine 25 mg;
2013-02-26;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02402424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88726
APO-TETRABENAZINE;
tetrabenazine 25 mg;
2013-11-01;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
DIN: 02407590
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89232
TETRABENAZINE TABLETS;
tetrabenazine 25 mg;
2013-08-29;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
STERIMAX INC
DIN: 02410338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89497
AMETOP GEL 4%;
tetracaine (tetracaine hydrochloride) 40 mg / g;
1998-03-16;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
VALEO PHARMA INC
DIN: 02230575
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49664
MINIMS TETRACAINE HYDROCHLORIDE;
tetracaine hydrochloride 0.5 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:16.00 – LOCAL ANESTHETICS;
Otc;
BAUSCH HEALTH, CANADA INC.
DIN: 02148528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18751
MINIMS TETRACAINE HYDROCHLORIDE;
tetracaine hydrochloride 1 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:16.00 – LOCAL ANESTHETICS;
Otc;
BAUSCH HEALTH, CANADA INC.
DIN: 02148544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18749
SYNACTHEN DEPOT;
tetracosactide (tetracosactide zinc hydroxide) 1 mg / ml;
1973-12-31;
Intramuscular;
Suspension;
36:04.00 – ADRENOCORTICAL INSUFFICIENCY , 68:04.00 – ADRENALS;
Prescription;
ATNAHS PHARMA UK LIMITED
DIN: 00253952
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3725
CORTROSYN INJ 0.25MG;
tetracosactide 0.25 mg / vial;
1974-12-31;
Intramuscular , Intravenous;
Powder For Solution;
36:04.00 – ADRENOCORTICAL INSUFFICIENCY , 68:28.00 – PITUITARY;
Prescription;
AMPHASTAR PHARMACEUTICALS, INC.
DIN: 00022381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1954
TETRACYCLINE;
tetracycline hydrochloride 250 mg;
1983-12-31;
Oral;
Capsule;
08:12.24 – TETRACYCLINES;
Prescription;
AA PHARMA INC
DIN: 00580929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5293
VISINE ORIGINAL;
tetrahydrozoline hydrochloride 0.05 %;
1960-12-31;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
JOHNSON & JOHNSON INC
DIN: 01942425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42015
ORIGINAL EYE DROPS;
tetrahydrozoline hydrochloride 0.05 % / w/v;
2006-06-05;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
DIN: 02273446
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75893
THALOMID;
thalidomide 100 mg;
2011-02-17;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
CELGENE INC
DIN: 02355205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84046
THALOMID;
thalidomide 200 mg;
2011-02-17;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
CELGENE INC
DIN: 02355221
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84048
THALOMID;
thalidomide 50 mg;
2010-11-01;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
CELGENE INC
DIN: 02355191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84045
AA-THEO LA;
theophylline 100 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
DIN: 00692689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14033
AA-THEO LA;
theophylline 200 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
DIN: 00692697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14032
AA-THEO LA;
theophylline 300 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
DIN: 00692700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14031
THEO ER;
theophylline 400 mg;
2011-06-23;
Oral;
Tablet (Extended-Release);
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
DIN: 02360101
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84507
THEO ER;
theophylline 600 mg;
2011-06-23;
Oral;
Tablet (Extended-Release);
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
DIN: 02360128
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84508
ELIXIR DE THEOPHYLLINE;
theophylline 80 mg / 15 ml;
1985-12-31;
Oral;
Elixir;
86:16.00 – RESPIRATORY SMOOTH MUSCLE RELAXANTS;
Prescription;
LABORATOIRE ATLAS INC
DIN: 00627410
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6170
VITAMIN B1;
thiamine hydrochloride 100 mg / ml;
1989-12-31;
Intramuscular , Intravenous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00816078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10063
THIAMIJECT INJECTION – LIQ IM IV 100MG/ML;
thiamine hydrochloride 100 mg / ml;
1998-07-16;
Intramuscular , Intravenous;
Liquid;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02193221
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35700
LANVIS;
thioguanine 40 mg;
1974-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 00282081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1812
TEPADINA;
thiotepa 100 mg / vial;
2017-10-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ADIENNE SA
DIN: 02462702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95051
TEPADINA;
thiotepa 15 mg / vial;
2017-11-06;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ADIENNE SA
DIN: 02462680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95050
THYROID TAB 125MG;
thyroid 125 mg;
1951-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
ERFA CANADA 2012 INC
DIN: 00023965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=774
THYROID TAB 30MG;
thyroid 30 mg;
1951-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
ERFA CANADA 2012 INC
DIN: 00023949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=772
THYROID TAB 60MG;
thyroid 60 mg;
1951-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
ERFA CANADA 2012 INC
DIN: 00023957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=773
THYROGEN;
thyrotropin alfa 0.9 mg / vial;
2002-08-12;
Intramuscular;
Powder For Solution;
36:60.00 – THYROID FUNCTION;
Prescription , Schedule D;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN: 02246016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70142
TEVA-TIAPROFENIC ACID;
tiaprofenic acid 200 mg;
1996-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02179679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19720
TEVA-TIAPROFENIC ACID;
tiaprofenic acid 300 mg;
1996-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02179687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19722
TIBELLA;
tibolone 2.5 mg;
2020-07-29;
Oral;
Tablet;
68:16.00 – ESTROGENS,ANTIESTROGENS,ESTROGEN AGONIST-ANTAGONISTS;
Schedule G (Cdsa Iv);
BIOSYENT PHARMA INC
DIN: 02488361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97847
BRILINTA;
ticagrelor 60 mg;
2016-06-13;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02455005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94181
BRILINTA;
ticagrelor 90 mg;
2011-06-01;
Oral;
Tablet;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02368544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85352
TYGACIL;
tigecycline 50 mg / vial;
2006-11-30;
Intravenous;
Powder For Solution;
08:12.24.12 – GLYCYLCYCLINES;
Prescription;
PFIZER CANADA ULC
DIN: 02285401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77090
TIGECYCLINE;
tigecycline 50 mg / vial;
2014-10-23;
Intravenous;
Powder For Solution;
08:12.24.12 – GLYCYLCYCLINES;
Prescription;
APOTEX INC
DIN: 02409356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89406
SANDOZ TIMOLOL;
timolol (timolol maleate) 0.25 %;
1995-12-31;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02166712
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19252
TIMOLOL MALEATE-EX;
timolol (timolol maleate) 0.25 %;
2003-04-30;
Ophthalmic;
Solution (Extended Release);
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02242275
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65975
TIMOPTIC;
timolol (timolol maleate) 0.5 %;
1979-12-31;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
ELVIUM LIFE SCIENCES
DIN: 00451207
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3186
APO-TIMOP;
timolol (timolol maleate) 0.5 %;
1988-12-31;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
APOTEX INC
DIN: 00755834
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8959
TIMOPTIC-XE;
timolol (timolol maleate) 0.5 %;
1995-12-31;
Ophthalmic;
Solution (Extended Release);
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
ELVIUM LIFE SCIENCES
DIN: 02171899
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18778
SANDOZ TIMOLOL;
timolol (timolol maleate) 0.5 %;
1995-12-31;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02166720
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19242
TIMOLOL MALEATE-EX;
timolol (timolol maleate) 0.5 %;
2003-04-30;
Ophthalmic;
Solution (Extended Release);
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02242276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65976
JAMP-TIMOLOL;
timolol (timolol maleate) 0.5 %;
2015-11-20;
Ophthalmic;
Solution;
52:40.08 – BETA-ADRENERGIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02447800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93340
TIMOLOL;
timolol maleate 10 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
AA PHARMA INC
DIN: 00755850
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8590
TIMOLOL;
timolol maleate 20 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
AA PHARMA INC
DIN: 00755869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8591
TIMOLOL;
timolol maleate 5 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
AA PHARMA INC
DIN: 00755842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8589
INNOHEP;
tinzaparin sodium 10000 unit / ml;
1995-12-31;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02167840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19202
INNOHEP;
tinzaparin sodium 10000 unit / ml;
1997-07-31;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02229755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47983
INNOHEP;
tinzaparin sodium 10000 unit / ml;
2011-09-09;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02358158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84321
INNOHEP;
tinzaparin sodium 10000 unit / ml;
2011-12-10;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02358166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84322
INNOHEP;
tinzaparin sodium 12000 unit / 0.6 ml;
2014-09-30;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02429470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91393
INNOHEP;
tinzaparin sodium 16000 unit / 0.8 ml;
2014-09-30;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02429489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91394
INNOHEP;
tinzaparin sodium 20000 unit / ml;
1997-02-28;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02229515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47420
INNOHEP;
tinzaparin sodium 20000 unit / ml;
1997-09-23;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02231478
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50802
INNOHEP;
tinzaparin sodium 20000 unit / ml;
2011-09-16;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02358174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84323
INNOHEP;
tinzaparin sodium 20000 unit / ml;
2011-09-13;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02358182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84324
INNOHEP;
tinzaparin sodium 8000 unit / 0.4 ml;
2014-09-30;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
LEO PHARMA INC
DIN: 02429462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91392
SPIRIVA;
tiotropium (tiotropium bromide monohydrate) 18 mcg;
2002-11-21;
Inhalation;
Capsule;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02246793
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70993
SPIRIVA RESPIMAT;
tiotropium (tiotropium bromide monohydrate) 2.5 mcg / act;
2014-12-19;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02435381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91971
APTIVUS;
tipranavir 250 mg;
2005-12-01;
Oral;
Capsule;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02273322
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75881
AGGRASTAT;
tirofiban (tirofiban hydrochloride) 12.5 mg / 250 ml;
2002-05-01;
Intravenous;
Solution;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
CIPHER PHARMACEUTICALS INC
DIN: 02240706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64293
KYMRIAH;
tisagenlecleucel 600000000 cells;
2019-05-24;
Intravenous;
Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02480514
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97104
TIZANIDINE;
tizanidine (tizanidine hydrochloride) 4 mg;
2004-11-17;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
AA PHARMA INC
DIN: 02259893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74515
TOBRAMYCIN FOR INJECTION;
tobramycin (tobramycin sulfate) 1.2 g / vial;
1983-12-31;
Intravenous;
Powder For Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 00533688
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5402
TOBRAMYCIN INJECTION USP;
tobramycin (tobramycin sulfate) 10 mg / ml;
1999-12-20;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02241209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64815
TOBI;
tobramycin (tobramycin sulfate) 300 mg / 5 ml;
1999-04-28;
Inhalation;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
BGP PHARMA ULC
DIN: 02239630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63101
TOBRAMYCIN INHALATION SOLUTION;
tobramycin (tobramycin sulfate) 300 mg / 5 ml;
2016-02-26;
Inhalation;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02443368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92802
TOBRAMYCIN INJECTION;
tobramycin (tobramycin sulfate) 40 mg / ml;
1997-05-21;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02230640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49817
TOBRAMYCIN INJECTION USP;
tobramycin (tobramycin sulfate) 40 mg / ml;
1999-12-20;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02241210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64816
TOBRAMYCIN INJECTION USP;
tobramycin (tobramycin sulfate) 40 mg / ml;
2021-02-17;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
STERIMAX INC
DIN: 02502372
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99195
TEVA-TOBRAMYCIN;
tobramycin (tobramycin sulfate) 60 mg / ml;
2016-02-03;
Inhalation;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
TEVA CANADA LIMITED
DIN: 02389622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87512
SANDOZ TOBRAMYCIN;
tobramycin 0.3 %;
2000-08-21;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02241755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65418
TOBREX;
tobramycin 0.3 % / w/v;
1981-12-31;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00513962
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4571
TOBREX;
tobramycin 0.3 % / w/w;
1984-12-31;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00614254
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5707
TOBI PODHALER;
tobramycin 28 mg;
2011-05-12;
Inhalation;
Capsule;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
BGP PHARMA ULC
DIN: 02365154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85000
ACTEMRA;
tocilizumab 162 mg / 0.9 ml;
2014-05-30;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02424770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90943
ACTEMRA;
tocilizumab 162 mg / 0.9 ml;
2019-01-15;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02483327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97376
ACTEMRA;
tocilizumab 200 mg / 10 ml;
2010-05-26;
Intravenous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02350106
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83534
ACTEMRA;
tocilizumab 400 mg / 20 ml;
2010-05-26;
Intravenous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02350114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83535
ACTEMRA;
tocilizumab 80 mg / 4 ml;
2010-05-26;
Intravenous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02350092
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83533
XELJANZ;
tofacitinib (tofacitinib citrate) 10 mg;
2019-01-30;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02480786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97137
XELJANZ XR;
tofacitinib (tofacitinib citrate) 11 mg;
2018-03-29;
Oral;
Tablet (Extended-Release);
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02470608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95960
XELJANZ;
tofacitinib (tofacitinib citrate) 5 mg;
2014-06-03;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02423898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90863
PROCLEARZ ANTIFUNGAL LIQUID;
tolnaftate 1 %;
1998-10-09;
Topical;
Solution;
84:04.08.40 – THIOCARBAMATES;
Otc;
PROFOOT INC.
DIN: 02078341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27993
TOLNAFTATE CREAM USP, 1%;
tolnaftate 1 %;
2010-03-10;
Topical;
Cream;
84:04.08.40 – THIOCARBAMATES;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02226707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37941
FLEXITOL MEDICATED ANTI-FUNGAL CREAM;
tolnaftate 1 %;
2008-09-12;
Topical;
Cream;
84:04.08.40 – THIOCARBAMATES;
Otc;
LACORIUM HEALTH INTERNATIONAL PTY LTD.
DIN: 02295873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78123
TINACTIN CHILL LIQUID SPRAY;
tolnaftate 1 %;
2009-07-15;
Topical;
Aerosol;
84:04.08.40 – THIOCARBAMATES;
Otc;
BAYER INC
DIN: 02319314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80479
TINACTIN;
tolnaftate 1 % / w/w;
1965-12-31;
Topical;
Cream;
84:04.08.40 – THIOCARBAMATES;
Otc;
BAYER INC
DIN: 00576034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41608
TINACTIN POWDER;
tolnaftate 1 % / w/w;
1965-12-31;
Topical;
Powder;
84:04.08.40 – THIOCARBAMATES;
Otc;
BAYER INC
DIN: 00576042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41611
TINACTIN AEROSOL POWDER;
tolnaftate 1 % / w/w;
1983-12-31;
Topical;
Aerosol , Powder;
84:04.08.40 – THIOCARBAMATES;
Otc;
BAYER INC
DIN: 00576050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41612
DR. SCHOLL’S ATHLETE’S FOOT SPRAY POWDER;
tolnaftate 1 % / w/w;
1989-12-31;
Topical;
Aerosol , Powder;
84:04.08.40 – THIOCARBAMATES;
Otc;
SCHOLL’S WELLNESS COMPANY
DIN: 01919245
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41933
ODOR-EATERS;
tolnaftate 1 % / w/w;
2002-03-07;
Topical;
Aerosol;
84:04.08.40 – THIOCARBAMATES;
Otc;
BLISTEX CORPORATION
DIN: 02244777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68767
TINACTIN CHILL DEODORANT POWDER SPRAY;
tolnaftate 1 % / w/w;
2009-07-18;
Topical;
Aerosol , Powder;
84:04.08.40 – THIOCARBAMATES;
Otc;
BAYER INC
DIN: 02319276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80475
FOOTWORKS HEALTHY ANTIFUNGAL SPRAY FOR ATHLETE’S FOOT;
tolnaftate 1 % / w/w;
2012-02-29;
Topical;
Spray;
84:04.08.40 – THIOCARBAMATES;
Otc;
THE AVON COMPANY CANADA LIMITED
DIN: 02375397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86080
FORMULA 3;
tolnaftate 1 % / w/w;
2014-01-16;
Topical;
Solution;
84:04.08.40 – THIOCARBAMATES;
Otc;
THE TETRA CORPORATION
DIN: 02413760
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89839
FOOT CARE FOAM;
tolnaftate 1 % / w/w;
2015-09-30;
Topical;
Aerosol, Foam;
84:04.08.40 – THIOCARBAMATES;
Otc;
NSC PHARMA GMBH & CO.KG
DIN: 02431718
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91618
FUNGIFOAM ANTIFUNGAL;
tolnaftate 1 % / w/w;
2019-04-02;
Topical;
Cream;
84:04.08.40 – THIOCARBAMATES;
Otc;
THE TETRA CORPORATION
DIN: 02480166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97070
DETROL;
tolterodine tartrate 1 mg;
1998-11-26;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
UPJOHN CANADA ULC
DIN: 02239064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62518
TEVA-TOLTERODINE;
tolterodine tartrate 1 mg;
2015-12-16;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
DIN: 02299593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78497
MINT-TOLTERODINE;
tolterodine tartrate 1 mg;
2015-12-16;
Oral;
Tablet;
86:12.00 – GENITOURINARY SMOOTH MUSCLE RELAXANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02423308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90805
DETROL;
tolterodine tartrate 2 mg;
1998-11-23;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
UPJOHN CANADA ULC
DIN: 02239065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62519
DETROL LA;
tolterodine tartrate 2 mg;
2002-03-26;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
UPJOHN CANADA ULC
DIN: 02244612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68599
TEVA-TOLTERODINE LA;
tolterodine tartrate 2 mg;
2015-12-16;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
DIN: 02412195
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89676
SANDOZ TOLTERODINE LA;
tolterodine tartrate 2 mg;
2015-12-16;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02413140
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89782
MINT-TOLTERODINE;
tolterodine tartrate 2 mg;
2015-12-16;
Oral;
Tablet;
86:12.00 – GENITOURINARY SMOOTH MUSCLE RELAXANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02423316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90806
DETROL LA;
tolterodine tartrate 4 mg;
2002-03-26;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
UPJOHN CANADA ULC
DIN: 02244613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68600
TEVA-TOLTERODINE LA;
tolterodine tartrate 4 mg;
2015-12-16;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
TEVA CANADA LIMITED
DIN: 02412209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89677
SANDOZ TOLTERODINE LA;
tolterodine tartrate 4 mg;
2015-12-16;
Oral;
Capsule (Extended Release);
86:12.04 – Antimuscarinics;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02413159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89783
SAMSCA;
tolvaptan 15 mg;
2011-09-22;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
DIN: 02370468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85561
SAMSCA;
tolvaptan 30 mg;
2011-09-22;
Oral;
Tablet;
40:28.28 – VASOPRESSIN ANTAGONISTS;
Prescription;
OTSUKA PHARMACEUTICAL CO LTD
DIN: 02370476
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85562
TOPAMAX 100MG;
topiramate 100 mg;
1997-03-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JANSSEN INC
DIN: 02230894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50172
TEVA-TOPIRAMATE;
topiramate 100 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02248861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73233
PMS-TOPIRAMATE;
topiramate 100 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02263009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74841
MYLAN-TOPIRAMATE;
topiramate 100 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02263378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74875
APO-TOPIRAMATE;
topiramate 100 mg;
2006-04-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02279630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76524
PRO-TOPIRAMATE;
topiramate 100 mg;
2008-10-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02313669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79916
MINT-TOPIRAMATE;
topiramate 100 mg;
2008-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02315653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80118
AURO-TOPIRAMATE;
topiramate 100 mg;
2011-11-28;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02345838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83125
TOPIRAMATE;
topiramate 100 mg;
2010-10-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02356864
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84198
TOPIRAMATE;
topiramate 100 mg;
2012-07-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02389487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87499
ACH-TOPIRAMATE;
topiramate 100 mg;
2012-12-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02395746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88080
TOPIRAMATE TABLETS USP;
topiramate 100 mg;
2014-11-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02430800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91524
SANDOZ TOPIRAMATE TABLETS;
topiramate 100 mg;
2014-10-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02431815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91629
JAMP-TOPIRAMATE;
topiramate 100 mg;
2015-02-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02435616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91995
AG-TOPIRAMATE;
topiramate 100 mg;
2018-07-26;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96681
TOPAMAX;
topiramate 15 mg;
1999-06-11;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JANSSEN INC
DIN: 02239907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63399
TOPAMAX 200MG;
topiramate 200 mg;
1997-03-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JANSSEN INC
DIN: 02230896
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50174
TEVA-TOPIRAMATE;
topiramate 200 mg;
2005-11-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02248862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73234
PMS-TOPIRAMATE;
topiramate 200 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02263017
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74842
MYLAN-TOPIRAMATE;
topiramate 200 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02263386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74876
APO-TOPIRAMATE;
topiramate 200 mg;
2006-04-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02279649
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76525
PRO-TOPIRAMATE;
topiramate 200 mg;
2008-10-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02313677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79917
MINT-TOPIRAMATE;
topiramate 200 mg;
2008-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02315661
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80119
AURO-TOPIRAMATE;
topiramate 200 mg;
2011-11-28;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02345846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83126
TOPIRAMATE;
topiramate 200 mg;
2010-10-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02356872
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84199
ACH-TOPIRAMATE;
topiramate 200 mg;
2012-11-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02395754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88081
TOPIRAMATE TABLETS USP;
topiramate 200 mg;
2014-11-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02430819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91525
SANDOZ TOPIRAMATE TABLETS;
topiramate 200 mg;
2014-10-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02431823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91630
JAMP-TOPIRAMATE;
topiramate 200 mg;
2015-02-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02435624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91996
TOPAMAX 25MG;
topiramate 25 mg;
1997-03-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JANSSEN INC
DIN: 02230893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50171
TOPAMAX;
topiramate 25 mg;
1999-06-11;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JANSSEN INC
DIN: 02239908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63400
TEVA-TOPIRAMATE;
topiramate 25 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02248860
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73232
PMS-TOPIRAMATE;
topiramate 25 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02262991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74840
MYLAN-TOPIRAMATE;
topiramate 25 mg;
2005-09-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02263351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74874
APO-TOPIRAMATE;
topiramate 25 mg;
2006-04-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02279614
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76522
PRO-TOPIRAMATE;
topiramate 25 mg;
2008-10-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02313650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79915
MINT-TOPIRAMATE;
topiramate 25 mg;
2008-10-02;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02315645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80117
AURO-TOPIRAMATE;
topiramate 25 mg;
2011-11-28;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02345803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83123
TOPIRAMATE;
topiramate 25 mg;
2010-10-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02356856
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84197
TOPIRAMATE;
topiramate 25 mg;
2012-07-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02389460
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87497
ACH-TOPIRAMATE;
topiramate 25 mg;
2012-11-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02395738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88079
TOPIRAMATE TABLETS USP;
topiramate 25 mg;
2014-11-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02430797
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91523
SANDOZ TOPIRAMATE TABLETS;
topiramate 25 mg;
2014-10-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02431807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91628
JAMP-TOPIRAMATE;
topiramate 25 mg;
2015-02-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02435608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91994
AG-TOPIRAMATE;
topiramate 25 mg;
2018-07-26;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96680
PMS-TOPIRAMATE;
topiramate 50 mg;
2008-06-17;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02312085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79760
TOPOTECAN HYDROCHLORIDE FOR INJECTION;
topotecan (topotecan hydrochloride) 1 mg / ml;
2012-03-27;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02379422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86529
TOPOTECAN INJECTION;
topotecan (topotecan hydrochloride) 1 mg / ml;
2014-02-05;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02390981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87637
TOPOTECAN HYDROCHLORIDE FOR INJECTION;
topotecan (topotecan hydrochloride) 1 mg / ml;
2013-11-21;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02396378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88140
TEVA-TOPOTECAN;
topotecan (topotecan hydrochloride) 4 mg / vial;
2015-11-17;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02441071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92544
PFIZER-BIONTECH COVID-19 VACCINE;
tozinameran 30 mcg / 0.3 ml;
2020-12-14;
Intramuscular;
Suspension;
-;
Covid-19 – Io – Authorization , Schedule D;
BIONTECH MANUFACTURING GMBH
DIN: 02509210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99852
YONDELIS;
trabectedin 1 mg / vial;
2010-08-05;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
VALEO PHARMA INC
DIN: 02351528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83679
TRIDURAL;
tramadol hydrochloride 100 mg;
2007-08-14;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PALADIN LABS INC.
DIN: 02296381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78172
RALIVIA;
tramadol hydrochloride 100 mg;
2007-10-25;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02299194
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78458
ZYTRAM XL;
tramadol hydrochloride 100 mg;
2011-03-02;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
DIN: 02360349
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84531
DURELA;
tramadol hydrochloride 100 mg;
2012-03-19;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
CIPHER PHARMACEUTICALS INC
DIN: 02373017
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85814
TARO-TRAMADOL ER;
tramadol hydrochloride 100 mg;
2016-03-07;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02450429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93657
ZYTRAM XL;
tramadol hydrochloride 150 mg;
2006-12-07;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
DIN: 02286424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77188
ZYTRAM XL;
tramadol hydrochloride 200 mg;
2006-12-07;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
DIN: 02286432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77189
TRIDURAL;
tramadol hydrochloride 200 mg;
2007-08-14;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PALADIN LABS INC.
DIN: 02296403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78173
RALIVIA;
tramadol hydrochloride 200 mg;
2007-10-25;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02299208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78459
DURELA;
tramadol hydrochloride 200 mg;
2012-03-19;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
CIPHER PHARMACEUTICALS INC
DIN: 02373025
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85815
TARO-TRAMADOL ER;
tramadol hydrochloride 200 mg;
2016-05-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02450437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93658
ZYTRAM XL;
tramadol hydrochloride 300 mg;
2006-12-07;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
DIN: 02286440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77190
TRIDURAL;
tramadol hydrochloride 300 mg;
2007-08-14;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PALADIN LABS INC.
DIN: 02296411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78174
RALIVIA;
tramadol hydrochloride 300 mg;
2007-10-25;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02299216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78460
DURELA;
tramadol hydrochloride 300 mg;
2012-03-19;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
CIPHER PHARMACEUTICALS INC
DIN: 02373033
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85816
TARO-TRAMADOL ER;
tramadol hydrochloride 300 mg;
2016-05-27;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02450445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93659
ZYTRAM XL;
tramadol hydrochloride 400 mg;
2006-12-07;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
DIN: 02286459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77191
APO-TRAMADOL;
tramadol hydrochloride 50 mg;
2014-06-23;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Prescription;
APOTEX INC
DIN: 02426153
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91076
AURO-TRAMADOL;
tramadol hydrochloride 50 mg;
2019-04-11;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02479672
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97034
MAR-TRAMADOL;
tramadol hydrochloride 50 mg;
2019-07-18;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02480859
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97151
SANDOZ TRAMADOL;
tramadol hydrochloride 50 mg;
2021-03-26;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02493764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98375
JAMP TRAMADOL;
tramadol hydrochloride 50 mg;
2021-04-21;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02507005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99642
ZYTRAM XL;
tramadol hydrochloride 75 mg;
2011-03-02;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Prescription;
PURDUE PHARMA
DIN: 02360322
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84529
MEKINIST;
trametinib 0.5 mg;
2013-08-28;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02409623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89431
MEKINIST;
trametinib 2 mg;
2013-08-28;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02409658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89433
MAVIK;
trandolapril 0.5 mg;
1998-01-28;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BGP PHARMA ULC
DIN: 02231457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50773
SANDOZ TRANDOLAPRIL;
trandolapril 0.5 mg;
2018-07-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02325721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81109
PMS-TRANDOLAPRIL;
trandolapril 0.5 mg;
2018-05-18;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02357755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84285
TEVA-TRANDOLAPRIL;
trandolapril 0.5 mg;
2018-09-26;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02415429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90003
AURO-TRANDOLAPRIL;
trandolapril 0.5 mg;
2018-09-27;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02471868
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96106
MAVIK;
trandolapril 1 mg;
1998-01-07;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BGP PHARMA ULC
DIN: 02231459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50775
SANDOZ TRANDOLAPRIL;
trandolapril 1 mg;
2018-07-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02325748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81110
PMS-TRANDOLAPRIL;
trandolapril 1 mg;
2018-05-18;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02357763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84286
TEVA-TRANDOLAPRIL;
trandolapril 1 mg;
2018-09-26;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02415437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90004
AURO-TRANDOLAPRIL;
trandolapril 1 mg;
2018-09-27;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02471876
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96109
TRANDOLAPRIL;
trandolapril 1 mg;
2019-07-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02488698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97878
MAVIK;
trandolapril 2 mg;
1998-01-14;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BGP PHARMA ULC
DIN: 02231460
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50776
SANDOZ TRANDOLAPRIL;
trandolapril 2 mg;
2018-07-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02325756
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81111
PMS-TRANDOLAPRIL;
trandolapril 2 mg;
2018-05-18;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02357771
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84287
TEVA-TRANDOLAPRIL;
trandolapril 2 mg;
2018-09-26;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02415445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90005
AURO-TRANDOLAPRIL;
trandolapril 2 mg;
2018-09-27;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02471884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96110
TRANDOLAPRIL;
trandolapril 2 mg;
2019-07-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02488701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97879
MAVIK;
trandolapril 4 mg;
2003-11-01;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
BGP PHARMA ULC
DIN: 02239267
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62731
SANDOZ TRANDOLAPRIL;
trandolapril 4 mg;
2018-07-12;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02325764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81112
PMS-TRANDOLAPRIL;
trandolapril 4 mg;
2018-05-20;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02357798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84288
TEVA-TRANDOLAPRIL;
trandolapril 4 mg;
2018-09-26;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02415453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90006
AURO-TRANDOLAPRIL;
trandolapril 4 mg;
2018-09-27;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02471892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96111
TRANDOLAPRIL;
trandolapril 4 mg;
2019-07-09;
Oral;
Capsule;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02488728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97880
CYKLOKAPRON 100 MG/ML;
tranexamic acid 100 mg / ml;
1995-12-31;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
PFIZER CANADA ULC
DIN: 02064413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18371
TRANEXAMIC ACID INJECTION BP;
tranexamic acid 100 mg / ml;
2002-10-29;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02246365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70531
TRANEXAMIC ACID INJECTION BP;
tranexamic acid 100 mg / ml;
2012-11-15;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
STERIMAX INC
DIN: 02386933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87251
TRANEXAMIC ACID INJECTION;
tranexamic acid 100 mg / ml;
2013-03-27;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02392763
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87801
ERFA-TRANEXAMIC;
tranexamic acid 100 mg / ml;
2017-07-31;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
ERFA CANADA 2012 INC
DIN: 02457431
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94449
TRANEXAMIC ACID INJECTION;
tranexamic acid 100 mg / ml;
2021-06-09;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
AURO PHARMA INC
DIN: 02466015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95428
TRANEXAMIC ACID INJECTION;
tranexamic acid 100 mg / ml;
2021-04-30;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02497328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98715
CYKLOKAPRON 500 MG;
tranexamic acid 500 mg;
1995-12-31;
Oral;
Tablet;
20:28.16 – HEMOSTATICS;
Prescription;
PFIZER CANADA ULC
DIN: 02064405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18072
TRANEXAMIC ACID TABLETS;
tranexamic acid 500 mg;
2013-02-13;
Oral;
Tablet;
20:28.16 – HEMOSTATICS;
Prescription;
STERIMAX INC
DIN: 02401231
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88596
GD-TRANEXAMIC ACID;
tranexamic acid 500 mg;
2014-03-07;
Oral;
Tablet;
20:28.16 – HEMOSTATICS;
Prescription;
GENMED A DIVISION OF PFIZER CANADA ULC
DIN: 02409097
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89382
MAR-TRANEXAMIC ACID;
tranexamic acid 500 mg;
2020-06-04;
Oral;
Tablet;
20:28.16 – HEMOSTATICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02496232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98610
PARNATE;
tranylcypromine (tranylcypromine sulfate) 10 mg;
1992-12-31;
Oral;
Tablet;
28:16.04.12 – MONOAMINE OXIDASE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 01919598
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15231
OGIVRI;
trastuzumab 150 mg / vial;
2019-06-06;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
BGP PHARMA ULC
DIN: 02474425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96453
TRAZIMERA;
trastuzumab 150 mg / vial;
2019-10-22;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02483475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97383
HERZUMA;
trastuzumab 150 mg / vial;
2021-02-25;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
CELLTRION HEALTHCARE CO LTD
DIN: 02506211
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99555
KANJINTI;
trastuzumab 420 mg / vial;
2020-04-16;
Intravenous;
Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
DIN: 02496690
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98651
HERCEPTIN;
trastuzumab 440 mg / vial;
1999-08-23;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02240692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64277
HERZUMA;
trastuzumab 440 mg / vial;
2019-12-11;
Intravenous;
Kit , Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
CELLTRION HEALTHCARE CO LTD
DIN: 02480794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97138
TRAZIMERA;
trastuzumab 440 mg / vial;
2019-10-22;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02483467
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97382
HERCEPTIN SC;
trastuzumab 600 mg / 5 ml;
2018-10-12;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02480697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97124
KADCYLA;
trastuzumab emtansine 100 mg / vial;
2013-10-09;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02412365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89698
KADCYLA;
trastuzumab emtansine 160 mg / vial;
2018-10-24;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
DIN: 02473224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96263
IZBA;
travoprost 0.003 % / w/v;
2017-02-06;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02457997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94502
TRAVATAN Z;
travoprost 0.004 % / w/v;
2008-11-10;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02318008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80351
SANDOZ TRAVOPROST;
travoprost 0.004 % / w/v;
2014-08-15;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02413167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89784
PMS TRAZODONE HCL TAB 100MG;
trazodone hydrochloride 100 mg;
1993-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PHARMASCIENCE INC
DIN: 01937235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13780
APO-TRAZODONE TABLETS 100MG;
trazodone hydrochloride 100 mg;
1995-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
APOTEX INC
DIN: 02147645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18045
TEVA-TRAZODONE;
trazodone hydrochloride 100 mg;
1995-01-18;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02144271
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18190
TRAZODONE-100;
trazodone hydrochloride 100 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PRO DOC LIMITEE
DIN: 02164361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19937
TRAZODONE;
trazodone hydrochloride 100 mg;
2010-04-30;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
SANIS HEALTH INC
DIN: 02348780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83412
APO-TRAZODONE D TABLETS 150MG;
trazodone hydrochloride 150 mg;
1995-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
APOTEX INC
DIN: 02147653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18040
TEVA-TRAZODONE;
trazodone hydrochloride 150 mg;
1995-01-18;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02144298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18189
TRAZODONE-150 D;
trazodone hydrochloride 150 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PRO DOC LIMITEE
DIN: 02164388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19938
TRAZODONE;
trazodone hydrochloride 150 mg;
2010-04-30;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
SANIS HEALTH INC
DIN: 02348799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83413
PMS TRAZODONE HCL TAB 50MG;
trazodone hydrochloride 50 mg;
1993-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PHARMASCIENCE INC
DIN: 01937227
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4241
APO-TRAZODONE TABLETS 50MG;
trazodone hydrochloride 50 mg;
1995-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
APOTEX INC
DIN: 02147637
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18046
TEVA-TRAZODONE;
trazodone hydrochloride 50 mg;
1995-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02144263
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18191
TRAZODONE-50;
trazodone hydrochloride 50 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PRO DOC LIMITEE
DIN: 02164353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19936
TRAZODONE;
trazodone hydrochloride 50 mg;
2010-04-30;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
SANIS HEALTH INC
DIN: 02348772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83411
PMS-TRAZODONE;
trazodone hydrochloride 75 mg;
1998-02-17;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
PHARMASCIENCE INC
DIN: 02237339
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60663
REMODULIN;
treprostinil (treprostinil sodium) 1 mg / ml;
2004-04-30;
Intravenous , Subcutaneous;
Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
UNITED THERAPEUTICS CORPORATION
DIN: 02246552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70735
REMODULIN;
treprostinil (treprostinil sodium) 10 mg / ml;
2004-04-30;
Intravenous , Subcutaneous;
Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
UNITED THERAPEUTICS CORPORATION
DIN: 02246555
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70738
REMODULIN;
treprostinil (treprostinil sodium) 2.5 mg / ml;
2004-04-30;
Intravenous , Subcutaneous;
Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
UNITED THERAPEUTICS CORPORATION
DIN: 02246553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70736
REMODULIN;
treprostinil (treprostinil sodium) 5 mg / ml;
2004-04-30;
Intravenous , Subcutaneous;
Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
UNITED THERAPEUTICS CORPORATION
DIN: 02246554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70737
VITAMIN A ACID;
tretinoin 0.01 %;
1983-12-31;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 01926462
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12753
STIEVA-A;
tretinoin 0.01 % / w/w;
1986-12-31;
Topical;
Cream;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 00657204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6619
VITAMIN A ACID;
tretinoin 0.025 %;
1986-12-31;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 01926470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12754
STIEVA-A;
tretinoin 0.025 % / w/w;
1983-12-31;
Topical;
Cream;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 00578576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5168
RETIN-A;
tretinoin 0.025 % / w/w;
1991-12-31;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00443816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11153
RETIN-A MICRO;
tretinoin 0.04 % / w/w;
2005-08-30;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02264633
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75010
VITAMIN A ACID;
tretinoin 0.05 %;
1978-12-31;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 01926489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12544
STIEVA-A;
tretinoin 0.05 % / w/w;
1981-12-31;
Topical;
Cream;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 00518182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4220
RETIN-A;
tretinoin 0.05 % / w/w;
1991-12-31;
Topical;
Cream;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00443794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11152
RETIN-A MICRO;
tretinoin 0.1 % / w/w;
2001-08-01;
Topical;
Gel;
84:16.00 – CELL STIMULANTS AND PROLIFERANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02243914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67856
VESANOID;
tretinoin 10 mg;
1995-12-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
DIN: 02145839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18080
TRIADERM CRM 0.1%;
triamcinolone acetonide 0.1 %;
1979-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 00716960
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8573
ORACORT DENTAL PASTE 0.1%;
triamcinolone acetonide 0.1 %;
1992-12-31;
Dental;
Paste;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 01964054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13360
ARISTOCORT R;
triamcinolone acetonide 0.1 % / w/w;
1997-04-14;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02194031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35783
ARISTOCORT R;
triamcinolone acetonide 0.1 % / w/w;
1996-10-10;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02194058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35784
ARISTOCORT C;
triamcinolone acetonide 0.5 % / w/w;
1997-10-21;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02194066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35785
KENALOG-10 INJECTION 10MG/ML;
triamcinolone acetonide 10 mg / ml;
1966-12-31;
Intra-Articular , Intrabursal , Intradermal , Intrasynovial;
Suspension;
68:04.00 – ADRENALS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
DIN: 01999761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15482
TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP;
triamcinolone acetonide 40 mg / ml;
1993-12-31;
Intra-Articular , Intramuscular;
Suspension;
68:04.00 – ADRENALS;
Prescription;
STERIMAX INC
DIN: 01977563
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13998
KENALOG-40 INJECTION 40MG/ML;
triamcinolone acetonide 40 mg / ml;
1973-12-31;
Intra-Articular , Intramuscular;
Suspension;
68:04.00 – ADRENALS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
DIN: 01999869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15481
TRIESENCE;
triamcinolone acetonide 40 mg / ml;
2012-08-22;
Intravitreal;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02368676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85366
NASACORT AQ;
triamcinolone acetonide 55 mcg / act;
1996-12-31;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC
DIN: 02213834
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19807
NASACORT ALLERGY 24HR;
triamcinolone acetonide 55 mcg / act;
2015-07-06;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Otc;
SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC
DIN: 02417510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90220
APO-TRIAMCINOLONE AQ;
triamcinolone acetonide 55 mcg / act;
2016-06-15;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
APOTEX INC
DIN: 02437635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92202
TRISPAN;
triamcinolone hexacetonide 20 mg / ml;
2018-10-04;
Intra-Articular , Periarticular , Intrasynovial;
Suspension;
68:04.00 – ADRENALS;
Prescription;
MEDEXUS INC
DIN: 02470632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95963
TRIAZOLAM;
triazolam 0.25 mg;
1989-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
DIN: 00808571
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9575
TC ANTIBACTERIAL LOTION SOAP;
triclosan 0.2 % / w/w;
2010-05-06;
Topical;
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
RUBBERMAID COMMERCIAL PRODUCTS LLC
DIN: 02319128
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80459
BACTI-STAT 0.3%;
triclosan 0.3 %;
1991-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
DIN: 00779237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11537
ANTISEPTIC HAND SOAP LIQ 0.3%;
triclosan 0.3 %;
1992-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
INLAND/ALCARE
DIN: 01972286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13357
CROWN ANTISEPTIC HAND SOAP;
triclosan 0.3 %;
1994-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CROWN CHEMICAL PRODUCTS INC.
DIN: 02143968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17953
SIMPLY BOTANICAL SENSATION SOOTHING SKIN;
triclosan 0.3 %;
2002-11-26;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GERMIPHENE CORPORATION
DIN: 02238288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61685
BACTI-STAT AE;
triclosan 0.3 %;
1998-10-23;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
DIN: 02238676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62107
ECOCARE 250;
triclosan 0.3 %;
1999-04-30;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
DIN: 02239311
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62780
PROVON MEDICATED LOTION SOAP WITH TRICLOSAN;
triclosan 0.3 %;
2000-03-24;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
DIN: 02240142
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63657
DIGICLEAN ANTIBACTERIAL FOAM HAND SOAP;
triclosan 0.3 %;
2000-11-15;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
DIN: 02242846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66676
KEYSTONE ANTIBACTERIAL FOAM HAND SOAP;
triclosan 0.3 %;
2003-04-01;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
DIN: 02244052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67995
WINNING HANDS FOAMING ANTIBACTERIAL HAND CLEANSER;
triclosan 0.3 %;
2004-05-01;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BETCO CORPORATION
DIN: 02250985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73591
QFS ANTIMICROBIAL HAND SOAP WITH TRICLOSAN;
triclosan 0.3 %;
2005-10-01;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
DIN: 02269694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75505
PROVON MEDICATED FOAM HANDWASH WITH ADVANCED MOISTURIZERS;
triclosan 0.3 %;
2007-02-15;
Topical (Household);
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
DIN: 02278146
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76373
PRIME SOURCE ANTIBACTERIAL FOAM SOAP;
triclosan 0.3 %;
2007-01-08;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
DIN: 02278154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76374
ANTIBACTERIAL CLEAN & SMOOTH;
triclosan 0.3 %;
2006-12-01;
Topical;
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ECOLAB CO
DIN: 02283816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76939
HFS ANTIMICROBIAL FOAM HAND SOAP WITH TRICLOSAN;
triclosan 0.3 %;
2007-02-15;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
DIN: 02286688
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77213
GOJO ANTIBACTERIAL PLUM SCENT FOAM HANDWASH TRICLOSAN LIQUID;
triclosan 0.3 % / w/w;
2012-04-16;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
DIN: 02375133
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86054
GOJO ANTIBACTERIAL FOAM HANDWASH TRICLOSAN LIQUID;
triclosan 0.3 % / w/w;
2012-04-16;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
DIN: 02375168
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86057
PRIME SOURCE ANTIBACTERIAL PLUM SCENT FOAM HANDWASH TRICLOSAN LIQUID;
triclosan 0.3 % / w/w;
2012-12-26;
Topical (Household);
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GOJO INDUSTRIES, INC.
DIN: 02389029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87455
BM-SAN;
triclosan 0.3 % / w/w;
2020-07-30;
Topical (Commercial);
Solution;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
LES CHIMIQUES B.O.D. INC
DIN: 02500930
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99058
ANTIBACTERIAL LOTION SOAP;
triclosan 0.4 % / w/w;
2007-09-17;
Topical (Commercial);
Lotion;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
CHARLOTTE PRODUCTS LTD.
DIN: 02249340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73418
ADASEPT LIQ 0.5%;
triclosan 0.5 %;
1973-12-31;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
ODAN LABORATORIES LTD
DIN: 00266507
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1668
ANTI-BAC – ASP 0.5%;
triclosan 0.5 %;
1999-09-30;
Topical;
Spray;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BENTFIELD EUROPE BV
DIN: 02219433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37869
ANTI-BAC FOAM SOAP;
triclosan 0.5 %;
2004-03-24;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
BENTFIELD EUROPE BV
DIN: 02245467
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69527
VALOUR ANTISEPTIC HAND CLEANSER;
triclosan 0.5 %;
2003-10-25;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
QWATRO CORPORATION
DIN: 02248405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72751
GENTLE FRESH DEFENSE;
triclosan 0.5 %;
2004-04-29;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
STATE INDUSTRIAL PRODUCTS
DIN: 02251604
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73652
INO-F ANTIBAC ANTIBACTERIAL HAND SOAP;
triclosan 0.5 %;
2005-04-21;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
GROUPE DISSAN INC.
DIN: 02267373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75280
ENRICHED FOAM ANTIBACTERIAL SOAP;
triclosan 0.5 %;
2010-05-04;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
RUBBERMAID COMMERCIAL PRODUCTS LLC
DIN: 02315513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80105
SPRAY ANTIBACTERIAL SOAP;
triclosan 0.5 % / w/w;
2010-05-04;
Topical;
Liquid;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Otc;
RUBBERMAID COMMERCIAL PRODUCTS LLC
DIN: 02315505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80104
MAR-TRIENTINE;
trientine hydrochloride 250 mg;
2020-11-10;
Oral;
Capsule;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02504855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99424
AKLIEF;
trifarotene 50 mcg / g;
2019-11-28;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
DIN: 02494175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98421
TRIFLUOPERAZINE;
trifluoperazine (trifluoperazine hydrochloride) 10 mg;
1975-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 00326836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2300
TRIFLUOPERAZINE;
trifluoperazine (trifluoperazine hydrochloride) 20 mg;
1984-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 00595942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5732
TRIFLUOPERAZINE;
trifluoperazine (trifluoperazine hydrochloride) 5 mg;
1975-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 00312746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2209
VIROPTIC;
trifluridine 1 %;
1987-12-31;
Ophthalmic;
Solution;
52:04.20 – ANTIVIRALS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00687456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8203
DOJOLVI;
triheptanoin 100 % / w/w;
2021-04-01;
Oral;
Liquid;
40:20.00 – CALORIC AGENTS;
Prescription;
ULTRAGENYX PHARMACEUTICAL INC
DIN: 02512556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100183
TRIHEXYPHENIDYL;
trihexyphenidyl hydrochloride 2 mg;
1982-12-31;
Oral;
Tablet;
28:36.08 – ANTICHOLINERGIC AGENTS;
Prescription;
AA PHARMA INC
DIN: 00545058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4901
TRIHEXYPHENIDYL;
trihexyphenidyl hydrochloride 5 mg;
1982-12-31;
Oral;
Tablet;
28:36.08 – ANTICHOLINERGIC AGENTS;
Prescription;
AA PHARMA INC
DIN: 00545074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4903
TRIMEBUTINE;
trimebutine maleate 100 mg;
2002-10-21;
Oral;
Tablet;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 56:32.00 – PROKINETIC AGENTS;
Prescription;
AA PHARMA INC
DIN: 02245663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69763
TRIMEBUTINE;
trimebutine maleate 200 mg;
2002-10-21;
Oral;
Tablet;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS , 56:32.00 – PROKINETIC AGENTS;
Prescription;
AA PHARMA INC
DIN: 02245664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69764
PANECTYL TAB 2.5MG;
trimeprazine (trimeprazine tartrate) 2.5 mg;
1959-12-31;
Oral;
Tablet;
04:04.12 – PHENOTHIAZINE DERIVATIVES;
Prescription;
ERFA CANADA 2012 INC
DIN: 01926306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12419
PANECTYL TAB 5MG;
trimeprazine (trimeprazine tartrate) 5 mg;
1959-12-31;
Oral;
Tablet;
04:04.12 – PHENOTHIAZINE DERIVATIVES;
Prescription;
ERFA CANADA 2012 INC
DIN: 01926292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12651
TRIMETHOPRIM TABLETS;
trimethoprim 100 mg;
2001-01-01;
Oral;
Tablet;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
AA PHARMA INC
DIN: 02243116
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66985
TRIMETHOPRIM TABLETS;
trimethoprim 200 mg;
2001-07-30;
Oral;
Tablet;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
AA PHARMA INC
DIN: 02243117
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66986
TRIMIPRAMINE;
trimipramine (trimipramine maleate) 100 mg;
1987-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 00740829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8106
TRIMIPRAMINE;
trimipramine (trimipramine maleate) 12.5 mg;
1987-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 00740799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8065
TRIMIPRAMINE;
trimipramine (trimipramine maleate) 25 mg;
1987-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 00740802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8066
TRIMIPRAMINE;
trimipramine (trimipramine maleate) 50 mg;
1987-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 00740810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8067
TRIMIPRAMINE;
trimipramine (trimipramine maleate) 75 mg;
1994-12-31;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 02070987
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15592
TRELSTAR;
triptorelin (triptorelin pamoate) 11.25 mg / vial;
2005-12-15;
Intramuscular;
Powder For Suspension, Sustained-Release;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
KNIGHT THERAPEUTICS INC.
DIN: 02243856
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67797
TRELSTAR;
triptorelin (triptorelin pamoate) 22.5 mg / vial;
2013-10-16;
Intramuscular;
Powder For Suspension, Sustained-Release;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
KNIGHT THERAPEUTICS INC.
DIN: 02412322
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89690
TRELSTAR;
triptorelin (triptorelin pamoate) 3.75 mg / vial;
2005-12-15;
Intramuscular;
Powder For Suspension, Sustained-Release;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
KNIGHT THERAPEUTICS INC.
DIN: 02240000
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63507
DECAPEPTYL;
triptorelin acetate 0.1 mg / ml;
2012-08-09;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
FERRING INC
DIN: 02389282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87478
MYOFLEX REGULAR STRENGTH;
trolamine salicylate 10 % / w/w;
1996-12-31;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
EXZELL PHARMA INC
DIN: 02152827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42699
NO ODOUR PAIN RELIEF CREAM;
trolamine salicylate 13.3 %;
2012-03-07;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
CRLS
DIN: 02358131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84320
MUSCLE & JOINT NO ODOUR REGULAR STRENGTH;
trolamine salicylate 13.3 %;
2018-08-31;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 02473143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96250
EXTRA STRENGTH ASPERCREME CREME RUB 15%;
trolamine salicylate 15 %;
1984-12-31;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC
DIN: 02074702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42373
MYOFLEX EXTRA STRENGTH;
trolamine salicylate 15 % / w/w;
1989-12-30;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
EXZELL PHARMA INC
DIN: 02226022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33476
MUSCLE & JOINT NO ODOUR EXTRA STRENGTH;
trolamine salicylate 20 %;
2018-09-24;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
CHURCH & DWIGHT CANADA CORP
DIN: 02473135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96248
MYOFLEX MAXIMUM STRENGTH;
trolamine salicylate 20 % / w/w;
2002-03-01;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
EXZELL PHARMA INC
DIN: 02244573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68558
ULTRA STRENGTH PAIN RELIEF RUB;
trolamine salicylate 20 % / w/w;
2017-03-27;
Topical;
Cream;
28:08.04.24 – SALICYLATES;
Otc;
CRLS
DIN: 02413442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89811
MYDRIACYL;
tropicamide 0.5 % / w/v;
1951-12-31;
Ophthalmic;
Solution;
52:24.00 – MYDRIATICS;
Prescription;
ALCON CANADA INC
DIN: 00000981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=260
MYDRIACYL;
tropicamide 1 % / w/v;
1969-12-31;
Ophthalmic;
Solution;
52:24.00 – MYDRIATICS;
Prescription;
ALCON CANADA INC
DIN: 00001007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=780
MINIMS TROPICAMIDE;
tropicamide 1 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
52:24.00 – MYDRIATICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02148536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18758
TROSEC;
trospium chloride 20 mg;
2006-04-04;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
DIN: 02275066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76057
MAR-TROSPIUM;
trospium chloride 20 mg;
2019-06-21;
Oral;
Tablet;
86:12.04 – Antimuscarinics;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02488353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97846
D.O.R.C. VISION BLUE;
trypan blue 0.06 %;
2006-09-06;
Intraocular;
Drops;
36:58.00 – OCULAR DISORDERS;
Ethical;
DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV
DIN: 02279525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76514
TRYPTAN;
tryptophan 1 g;
1986-12-31;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00654531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7264
TEVA-TRYPTOPHAN;
tryptophan 1 g;
1998-08-07;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02237250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60571
APO-TRYPTOPHAN;
tryptophan 1 g;
2003-12-09;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
APOTEX INC
DIN: 02248539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72893
TRYPTAN;
tryptophan 250 mg;
1999-01-06;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02239326
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62795
TRYPTAN;
tryptophan 500 mg;
1986-12-31;
Oral;
Capsule;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00718149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7263
TRYPTAN;
tryptophan 500 mg;
1994-12-31;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02029456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15485
TEVA-TRYPTOPHAN;
tryptophan 500 mg;
1999-09-28;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02240333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63872
TEVA-TRYPTOPHAN;
tryptophan 500 mg;
2000-02-23;
Oral;
Capsule;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02240334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63873
APO-TRYPTOPHAN;
tryptophan 500 mg;
2003-12-09;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
APOTEX INC
DIN: 02248538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72892
APO-TRYPTOPHAN;
tryptophan 500 mg;
2003-12-09;
Oral;
Capsule;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
APOTEX INC
DIN: 02248540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72895
TRYPTAN;
tryptophan 750 mg;
1999-01-06;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02239327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62796
APO-TRYPTOPHAN;
tryptophan 750 mg;
2017-02-06;
Oral;
Tablet;
28:16.04 – ANTIDEPRESSANTS;
Prescription;
APOTEX INC
DIN: 02458721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94588
TUKYSA;
tucatinib 150 mg;
2020-08-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SEATTLE GENETICS, INC.
DIN: 02499835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98956
TUKYSA;
tucatinib 50 mg;
2020-10-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SEATTLE GENETICS, INC.
DIN: 02499827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98955
ZONOVATE;
turoctocog alfa 1000 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02435209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91948
ZONOVATE;
turoctocog alfa 1500 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02435217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91949
ZONOVATE;
turoctocog alfa 2000 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02435225
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91950
ZONOVATE;
turoctocog alfa 250 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02435187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91946
ZONOVATE;
turoctocog alfa 3000 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02435233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91951
ZONOVATE;
turoctocog alfa 500 unit / vial;
2018-03-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02435195
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91947
ELLA;
ulipristal acetate 30 mg;
2015-09-01;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
LABORATOIRE HRA PHARMA
DIN: 02436329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92065
INCRUSE ELLIPTA;
umeclidinium (umeclidinium bromide) 62.5 mcg / act;
2015-04-27;
Inhalation;
Powder;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02423596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90830
RINVOQ;
upadacitinib 15 mg;
2020-01-16;
Oral;
Tablet (Extended-Release);
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
ABBVIE CORPORATION
DIN: 02495155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98509
URSO;
ursodiol 250 mg;
1998-11-08;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02238984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62432
PMS-URSODIOL C;
ursodiol 250 mg;
2006-05-01;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02273497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75898
GLN-URSODIOL;
ursodiol 250 mg;
2016-04-04;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
DIN: 02426900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91144
JAMP-URSODIOL;
ursodiol 250 mg;
2018-09-28;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02472392
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96170
AG-URSODIOL;
ursodiol 250 mg;
2021-04-30;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02505363
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99472
URSO DS;
ursodiol 500 mg;
2003-02-03;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02245894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70011
PMS-URSODIOL C;
ursodiol 500 mg;
2006-05-01;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02273500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75899
GLN-URSODIOL;
ursodiol 500 mg;
2016-04-04;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
DIN: 02426919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91146
JAMP-URSODIOL;
ursodiol 500 mg;
2018-09-28;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02472406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96171
AG-URSODIOL;
ursodiol 500 mg;
2021-04-30;
Oral;
Tablet;
56:14.00 – CHOLELITHOLYTIC AGENTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02505371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99473
STELARA;
ustekinumab 45 mg / 0.5 ml;
2009-01-05;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS , 92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
JANSSEN INC
DIN: 02320673
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80608
STELARA;
ustekinumab 5 mg / ml;
2016-12-21;
Intravenous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS , 92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
JANSSEN INC
DIN: 02459671
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94698
STELARA;
ustekinumab 90 mg / 1 ml;
2013-01-07;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS , 92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
JANSSEN INC
DIN: 02320681
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80609
SANDOZ VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride monohydrate) 500 mg;
2015-07-21;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02347091
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83249
VALTREX;
valacyclovir (valacyclovir hydrochloride) 1000 mg;
2005-05-09;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02246559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70742
MYLAN-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 1000 mg;
2010-05-25;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02351560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83684
APO-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 1000 mg;
2011-10-21;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
DIN: 02354705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83987
PMS-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 1000 mg;
2012-03-13;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PHARMASCIENCE INC
DIN: 02381230
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86701
VALTREX;
valacyclovir (valacyclovir hydrochloride) 500 mg;
1996-12-31;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02219492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20218
APO-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2008-05-23;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
DIN: 02295822
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78118
PMS-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2008-05-16;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PHARMASCIENCE INC
DIN: 02298457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78376
PRO-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2009-02-10;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PRO DOC LIMITEE
DIN: 02315173
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80073
RIVA-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2008-10-27;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02316447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80195
MYLAN-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2010-05-25;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02351579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83683
TEVA-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2010-10-01;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
TEVA CANADA LIMITED
DIN: 02357534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84264
AURO-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2013-05-30;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
AURO PHARMA INC
DIN: 02405040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88988
JAMP VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2021-04-13;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02440598
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92496
JAMP-VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2015-10-14;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02441454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92583
VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2015-10-14;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02442000
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92637
VALACYCLOVIR;
valacyclovir (valacyclovir hydrochloride) 500 mg;
2016-06-10;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
SANIS HEALTH INC
DIN: 02454645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94135
VALCYTE;
valganciclovir (valganciclovir hydrochloride) 450 mg;
2002-07-16;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02245777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69890
TEVA-VALGANCICLOVIR;
valganciclovir (valganciclovir hydrochloride) 450 mg;
2014-11-27;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
TEVA CANADA LIMITED
DIN: 02413825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89847
AURO-VALGANCICLOVIR;
valganciclovir (valganciclovir hydrochloride) 450 mg;
2015-04-10;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
AURO PHARMA INC
DIN: 02435179
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91945
MINT-VALGANCICLOVIR;
valganciclovir (valganciclovir hydrochloride) 450 mg;
2020-05-27;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02495457
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98537
VALCYTE;
valganciclovir (valganciclovir hydrochloride) 50 mg / ml;
2008-08-13;
Oral;
Powder For Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02306085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79164
EPIVAL;
valproic acid (divalproex sodium) 125 mg;
1984-12-31;
Oral;
Tablet (Delayed-Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BGP PHARMA ULC
DIN: 00596418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5676
APO-DIVALPROEX;
valproic acid (divalproex sodium) 125 mg;
1999-03-24;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02239698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63179
MYLAN-DIVALPROEX;
valproic acid (divalproex sodium) 125 mg;
2017-04-21;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02458926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94597
EPIVAL;
valproic acid (divalproex sodium) 250 mg;
1984-12-31;
Oral;
Tablet (Delayed-Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BGP PHARMA ULC
DIN: 00596426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5677
MYLAN-DIVALPROEX;
valproic acid (divalproex sodium) 250 mg;
2017-05-21;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02458934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94598
APO-DIVALPROEX;
valproic acid (divalproex sodium) 250 mg / ect;
1999-03-24;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02239699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63180
EPIVAL;
valproic acid (divalproex sodium) 500 mg;
1984-12-31;
Oral;
Tablet (Delayed-Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BGP PHARMA ULC
DIN: 00596434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5678
MYLAN-DIVALPROEX;
valproic acid (divalproex sodium) 500 mg;
2017-04-11;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02459019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94599
APO-DIVALPROEX;
valproic acid (divalproex sodium) 500 mg / ect;
1999-03-24;
Oral;
Tablet (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02239700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63181
DEPAKENE;
valproic acid (sodium valproate) 250 mg / 5 ml;
1978-12-31;
Oral;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BGP PHARMA ULC
DIN: 00443832
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3156
PMS-VALPROIC ACID;
valproic acid (sodium valproate) 250 mg / 5 ml;
1997-11-20;
Oral;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02236807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60096
APO-VALPROIC;
valproic acid (sodium valproate) 250 mg / 5 ml;
1998-07-15;
Oral;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02238370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61782
PMS-VALPROIC ACID;
valproic acid 250 mg;
1997-02-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02230768
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50031
APO-VALPROIC;
valproic acid 250 mg;
1998-06-01;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02238048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61432
PMS-VALPROIC ACID E.C.;
valproic acid 500 mg;
1996-12-13;
Oral;
Capsule (Enteric-Coated);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02229628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47553
DIOVAN 160MG TABLETS;
valsartan 160 mg;
2003-01-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02244782
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68772
TEVA-VALSARTAN;
valsartan 160 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02356678
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84180
SANDOZ VALSARTAN;
valsartan 160 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02356767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84189
TARO-VALSARTAN;
valsartan 160 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02363119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84813
VALSARTAN;
valsartan 160 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02366967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85178
VALSARTAN;
valsartan 160 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02367742
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85258
AURO-VALSARTAN;
valsartan 160 mg;
2014-02-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02414236
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89889
DIOVAN;
valsartan 320 mg;
2007-02-14;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02289504
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77486
TEVA-VALSARTAN;
valsartan 320 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02356686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84181
SANDOZ VALSARTAN;
valsartan 320 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02356775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84190
VALSARTAN;
valsartan 320 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02366975
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85179
VALSARTAN;
valsartan 320 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02367750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85259
AURO-VALSARTAN;
valsartan 320 mg;
2014-02-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02414244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89890
DIOVAN;
valsartan 40 mg;
2005-11-01;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02270528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75588
TEVA-VALSARTAN;
valsartan 40 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02356643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84178
SANDOZ VALSARTAN;
valsartan 40 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02356740
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84187
TARO-VALSARTAN;
valsartan 40 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02363062
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84808
VALSARTAN;
valsartan 40 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02366940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85176
VALSARTAN;
valsartan 40 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02367726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85256
AURO-VALSARTAN;
valsartan 40 mg;
2014-02-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02414201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89887
DIOVAN 80MG TABLETS;
valsartan 80 mg;
2003-01-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02244781
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68771
TEVA-VALSARTAN;
valsartan 80 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02356651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84179
SANDOZ VALSARTAN;
valsartan 80 mg;
2011-01-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02356759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84188
TARO-VALSARTAN;
valsartan 80 mg;
2011-02-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02363100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84812
VALSARTAN;
valsartan 80 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02366959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85177
VALSARTAN;
valsartan 80 mg;
2011-05-30;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02367734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85257
AURO-VALSARTAN;
valsartan 80 mg;
2014-02-06;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02414228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89888
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 1 g / vial;
1992-12-31;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02139383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19705
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2000-03-31;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
PFIZER CANADA ULC
DIN: 02230192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48885
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2010-09-23;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STERIMAX INC
DIN: 02342863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82836
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2014-03-18;
Intravenous;
Powder For Solution;
-;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02394634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87977
JAMP-VANCOMYCIN;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2014-09-22;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02420309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90489
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2017-07-17;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02435721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92007
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 1 g / vial;
2021-01-14;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02502607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99217
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 10 g / vial;
2000-07-10;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02241807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65472
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 10 g / vial;
2015-10-05;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
PFIZER CANADA ULC
DIN: 02378345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86416
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
vancomycin (vancomycin hydrochloride) 10 g / vial;
2013-06-12;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STERIMAX INC
DIN: 02405830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89060
VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE;
vancomycin (vancomycin hydrochloride) 1000 mg / 200 ml;
2021-01-11;
Intravenous;
Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
BAXTER CORPORATION
DIN: 02487071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97722
VANCOCIN;
vancomycin (vancomycin hydrochloride) 125 mg;
1989-12-31;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
SEARCHLIGHT PHARMA INC
DIN: 00800430
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9594
VANCOMYCIN HYDROCHLORIDE CAPSULES, USP;
vancomycin (vancomycin hydrochloride) 125 mg;
2021-01-25;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STRIDES PHARMA CANADA INC
DIN: 02406497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89119
JAMP VANCOMYCIN;
vancomycin (vancomycin hydrochloride) 125 mg;
2014-03-26;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02407744
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89245
VANCOCIN;
vancomycin (vancomycin hydrochloride) 250 mg;
1989-12-31;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
SEARCHLIGHT PHARMA INC
DIN: 00788716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9593
VANCOMYCIN HYDROCHLORIDE CAPSULES, USP;
vancomycin (vancomycin hydrochloride) 250 mg;
2021-01-25;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STRIDES PHARMA CANADA INC
DIN: 02406500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89120
JAMP VANCOMYCIN;
vancomycin (vancomycin hydrochloride) 250 mg;
2014-03-26;
Oral;
Capsule;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02407752
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89246
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 5 g / vial;
1996-08-14;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02139243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43933
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 5 g / vial;
2013-02-14;
Intravenous;
Powder For Solution;
-;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02394642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87978
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
vancomycin (vancomycin hydrochloride) 5 g / vial;
2020-10-19;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STERIMAX INC
DIN: 02405822
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89059
JAMP-VANCOMYCIN;
vancomycin (vancomycin hydrochloride) 5 g / vial;
2014-09-22;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02420317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90490
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
1992-12-31;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02139375
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19703
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
2000-03-31;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
PFIZER CANADA ULC
DIN: 02230191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48884
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
2010-09-23;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
STERIMAX INC
DIN: 02342855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82835
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
2014-03-18;
Intravenous;
Powder For Solution;
-;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02394626
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87976
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
2017-07-27;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02435713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92006
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP;
vancomycin (vancomycin hydrochloride) 500 mg / vial;
2021-01-14;
Intravenous;
Powder For Solution;
08:12.28.16 – GLYCOPEPTIDES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02502593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99216
CAPRELSA;
vandetanib 100 mg;
2012-02-23;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN: 02378582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86437
CAPRELSA;
vandetanib 300 mg;
2012-02-23;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN: 02378590
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86438
MYLAN-VARDENAFIL;
vardenafil (vardenafil hydrochloride trihydrate) 10 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02464225
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95239
JAMP-VARDENAFIL ODT;
vardenafil (vardenafil hydrochloride trihydrate) 10 mg;
2019-06-06;
Oral;
Tablet (Orally Disintegrating);
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02476088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96702
MYLAN-VARDENAFIL;
vardenafil (vardenafil hydrochloride trihydrate) 20 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02464233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95240
MYLAN-VARDENAFIL;
vardenafil (vardenafil hydrochloride trihydrate) 5 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02464209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95236
LEVITRA;
vardenafil (vardenafil hydrochloride) 10 mg;
2004-03-17;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
BAYER INC
DIN: 02250470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73527
STAXYN;
vardenafil (vardenafil hydrochloride) 10 mg;
2011-08-25;
Oral;
Tablet (Orally Disintegrating);
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
BAYER INC
DIN: 02372436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85755
APO-VARDENAFIL;
vardenafil (vardenafil hydrochloride) 10 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02471655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96087
JAMP-VARDENAFIL;
vardenafil (vardenafil hydrochloride) 10 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02475685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96606
LEVITRA;
vardenafil (vardenafil hydrochloride) 20 mg;
2004-03-17;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
BAYER INC
DIN: 02250489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73528
APO-VARDENAFIL;
vardenafil (vardenafil hydrochloride) 20 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02471663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96088
JAMP-VARDENAFIL;
vardenafil (vardenafil hydrochloride) 20 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02475693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96607
APO-VARDENAFIL;
vardenafil (vardenafil hydrochloride) 5 mg;
2018-12-21;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
APOTEX INC
DIN: 02471647
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96086
JAMP-VARDENAFIL;
vardenafil (vardenafil hydrochloride) 5 mg;
2018-11-01;
Oral;
Tablet;
24:12.12 – PHOSPHODIESTERASE TYPE 5 INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02475677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96605
CHAMPIX;
varenicline (varenicline tartrate) 0.5 mg;
2007-04-11;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
PFIZER CANADA ULC
DIN: 02291177
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77655
APO-VARENICLINE;
varenicline (varenicline tartrate) 0.5 mg;
2018-05-02;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
APOTEX INC
DIN: 02419882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90450
TEVA-VARENICLINE;
varenicline (varenicline tartrate) 0.5 mg;
2019-04-23;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
TEVA CANADA LIMITED
DIN: 02426226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91083
CHAMPIX;
varenicline (varenicline tartrate) 1 mg;
2007-04-11;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
PFIZER CANADA ULC
DIN: 02291185
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77656
APO-VARENICLINE;
varenicline (varenicline tartrate) 1 mg;
2018-05-02;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
APOTEX INC
DIN: 02419890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90451
TEVA-VARENICLINE;
varenicline (varenicline tartrate) 1 mg;
2019-04-23;
Oral;
Tablet;
12:92.00 – MISCELLANEOUS AUTONOMIC DRUGS;
Prescription;
TEVA CANADA LIMITED
DIN: 02426234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91084
VARIZIG;
varicella zoster immunoglobulin (human) 125 unit / vial;
2015-08-14;
Intramuscular , Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
SAOL THERAPEUTICS RESEARCH LIMITED
DIN: 02442183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92654
SHINGRIX;
varicella-zoster virus glycoprotein e antigen 50 mcg / 0.5 ml;
2018-01-02;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02468425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95685
VARIVAX III;
varicella-zoster virus vaccine live attenuated (oka/merck strain) 1350 unit / 0.5 ml;
2002-12-02;
Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
DIN: 02246081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70216
ZOSTAVAX II;
varicella-zoster virus vaccine live attenuated (oka/merck strain) 19400 pfu / 0.65 ml;
2014-05-26;
Subcutaneous;
Powder For Suspension;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
DIN: 02375516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86093
VASOPRESSIN INJECTION;
vasopressin 20 unit / ml;
1996-08-14;
Intramuscular , Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02139502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31359
VASOPRESSIN INJECTION USP;
vasopressin 20 unit / ml;
2003-12-10;
Intramuscular , Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02247938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72248
ENTYVIO;
vedolizumab 108 mg / 0.68 ml;
2020-11-20;
Subcutaneous;
Solution;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription , Schedule D;
TAKEDA CANADA INC
DIN: 02497875
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98766
ENTYVIO;
vedolizumab 108 mg / 0.68 ml;
2020-07-08;
Subcutaneous;
Solution;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription , Schedule D;
TAKEDA CANADA INC
DIN: 02497867
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98767
ENTYVIO;
vedolizumab 300 mg / vial;
2015-04-21;
Intravenous;
Powder For Solution;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription , Schedule D;
TAKEDA CANADA INC
DIN: 02436841
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92117
VPRIV;
velaglucerase alfa 400 unit / vial;
2010-11-22;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
TAKEDA CANADA INC
DIN: 02357119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84221
ZELBORAF;
vemurafenib 240 mg;
2012-03-05;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02380242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86606
VENCLEXTA;
venetoclax 10 mg;
2016-10-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ABBVIE CORPORATION
DIN: 02458039
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94509
VENCLEXTA;
venetoclax 100 mg;
2016-10-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ABBVIE CORPORATION
DIN: 02458055
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94511
VENCLEXTA;
venetoclax 50 mg;
2016-10-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ABBVIE CORPORATION
DIN: 02458047
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94510
EFFEXOR XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
1998-03-04;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 02237282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60603
TEVA-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2006-12-01;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02275058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76056
PMS-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2007-08-17;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02278561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76415
ACT VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2008-02-13;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02304333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78962
SANDOZ VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2008-05-09;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02310333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79598
APO-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2013-04-16;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02331705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81740
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2010-02-03;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02339269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82487
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2010-07-27;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02354748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83990
TARO-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2012-02-16;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02380099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86593
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2012-06-10;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385945
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87155
AURO-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2016-03-14;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02452855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93926
M-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2018-03-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02471302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96041
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 150 mg;
2019-08-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02489694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97976
EFFEXOR XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
1998-03-04;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 02237279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60600
TEVA-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2006-12-01;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02275023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76054
PMS-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2007-08-17;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02278545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76413
ACT VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2008-02-13;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02304317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78960
SANDOZ VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2008-05-09;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02310317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79596
APO-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2013-04-16;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02331683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81738
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2010-02-03;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02339242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82485
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2010-07-27;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02354713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83988
TARO-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2012-02-17;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02380072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86591
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2012-06-10;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87153
AURO-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2016-03-14;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02452839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93924
M-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2018-03-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02471280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96039
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 37.5 mg;
2019-08-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02489678
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97974
EFFEXOR XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
1998-03-04;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
UPJOHN CANADA ULC
DIN: 02237280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60601
TEVA-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2006-12-01;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02275031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76055
PMS-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2007-08-17;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02278553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76414
ACT VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2008-02-13;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02304325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78961
SANDOZ VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2008-05-09;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02310325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79597
APO-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2013-04-16;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02331691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81739
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2010-02-03;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02339250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82486
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2010-07-27;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02354721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83989
TARO-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2012-02-17;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02380080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86592
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2012-06-10;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87154
AURO-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2016-03-14;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02452847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93925
M-VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2018-03-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02471299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96040
VENLAFAXINE XR;
venlafaxine (venlafaxine hydrochloride) 75 mg;
2019-08-07;
Oral;
Capsule (Extended Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02489686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97975
APO-VERAP TABLET 120MG;
verapamil hydrochloride 120 mg;
1989-12-31;
Oral;
Tablet;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00782491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9940
ISOPTIN SR;
verapamil hydrochloride 120 mg;
1991-12-31;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 01907123
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11534
MYLAN-VERAPAMIL SR;
verapamil hydrochloride 120 mg;
1996-12-31;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02210347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20018
MYLAN-VERAPAMIL;
verapamil hydrochloride 120 mg;
1998-05-11;
Oral;
Tablet;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02237922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61287
ISOPTIN SR;
verapamil hydrochloride 180 mg;
1994-04-21;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 01934317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15585
MYLAN-VERAPAMIL SR;
verapamil hydrochloride 180 mg;
2016-06-29;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02450488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93662
VERAPAMIL HYDROCHLORIDE INJECTION USP;
verapamil hydrochloride 2.5 mg / ml;
1994-12-31;
Intravenous;
Solution;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 00839299
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17234
VERAPAMIL HYDROCHLORIDE INJECTION USP;
verapamil hydrochloride 2.5 mg / ml;
1995-12-31;
Intravenous;
Liquid;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02166739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18614
ISOPTIN SR;
verapamil hydrochloride 240 mg;
1988-12-31;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 00742554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9264
MYLAN-VERAPAMIL SR;
verapamil hydrochloride 240 mg;
2016-09-01;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02450496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93663
APO-VERAP TAB 80MG;
verapamil hydrochloride 80 mg;
1989-12-31;
Oral;
Tablet;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00782483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10034
MYLAN-VERAPAMIL;
verapamil hydrochloride 80 mg;
1998-05-25;
Oral;
Tablet;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02237921
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61286
BRINAVESS;
vernakalant hydrochloride 20 mg / ml;
2018-01-23;
Intravenous;
Solution;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
CIPHER PHARMACEUTICALS INC
DIN: 02462400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95016
VISUDYNE;
verteporfin 15 mg / vial;
2000-06-26;
Intravenous;
Powder For Solution;
52:92.00 – EENT DRUGS, MISCELLANEOUS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
DIN: 02242367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66078
SABRIL;
vigabatrin 500 mg;
1994-12-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LUNDBECK PHARMACEUTICALS LLC
DIN: 02065819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15532
SABRIL;
vigabatrin 500 mg / sachet;
1997-08-20;
Oral;
Powder For Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LUNDBECK PHARMACEUTICALS LLC
DIN: 02068036
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43682
VIIBRYD;
vilazodone hydrochloride 10 mg;
2018-01-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
ALLERGAN INC
DIN: 02443724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92846
VIIBRYD;
vilazodone hydrochloride 20 mg;
2018-01-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
ALLERGAN INC
DIN: 02443732
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92847
VIIBRYD;
vilazodone hydrochloride 40 mg;
2018-01-31;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
ALLERGAN INC
DIN: 02443740
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92848
VINBLASTINE SULFATE INJECTION;
vinblastine sulfate 1 mg / ml;
1998-04-14;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02183056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44270
VINBLASTINE SULPHATE INJECTION;
vinblastine sulfate 1 mg / ml;
2013-02-08;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02401460
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88636
VINCRISTINE SULFATE INJECTION;
vincristine sulfate 1 mg / ml;
1995-12-31;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02143305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19756
VINCRISTINE SULFATE INJECTION USP;
vincristine sulfate 1 mg / ml;
1997-08-07;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02183013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44267
VINORELBINE TARTRATE FOR INJECTION;
vinorelbine (vinorelbine tartrate) 10 mg / ml;
2007-05-09;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02271214
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75669
VINORELBINE INJECTION, USP;
vinorelbine (vinorelbine tartrate) 10 mg / ml;
2017-08-01;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02431130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91557
ERIVEDGE;
vismodegib 150 mg;
2013-08-09;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02409267
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89398
VITAMIN B12;
vitamin b12 1000 mcg / ml;
1978-12-31;
Intramuscular , Subcutaneous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00521515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4432
CYANOCOBALAMIN INJECTION USP;
vitamin b12 1000 mcg / ml;
1992-12-31;
Intramuscular , Subcutaneous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
STERIMAX INC
DIN: 01987003
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13324
CYANOCOBALAMIN INJECTION USP;
vitamin b12 1000 mcg / ml;
2018-01-16;
Intramuscular , Subcutaneous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02463393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95136
SANDOZ D-FORTE;
vitamin d2 50000 unit;
1999-12-30;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02237450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60784
D-FORTE;
vitamin d2 50000 unit;
2017-08-16;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
EURO-PHARM INTERNATIONAL CANADA INC
DIN: 02465426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95360
SANDOZ D 10 000;
vitamin d3 (cholecalciferol) 10000 unit;
2005-04-06;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02253178
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73813
EURO D 10 000;
vitamin d3 (cholecalciferol) 10000 unit;
2017-08-16;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
EURO-PHARM INTERNATIONAL CANADA INC
DIN: 02464594
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95272
D-TABS 10000UNIT;
vitamin d3 10000 unit;
1992-12-31;
Oral;
Tablet;
88:16.00 – VITAMIN D;
Prescription;
LABORATOIRE RIVA INC.
DIN: 00821772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12345
JAMP-VITAMIN D;
vitamin d3 10000 unit;
2012-05-02;
Oral;
Tablet;
88:16.00 – VITAMIN D;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02379007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86482
VIDEXTRA;
vitamin d3 10000 unit;
2014-03-20;
Oral;
Tablet;
88:16.00 – VITAMIN D;
Prescription;
ORIMED PHARMA INC
DIN: 02417685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90230
VITAMINE D 10 000;
vitamin d3 10000 unit;
2014-01-16;
Oral;
Tablet;
88:16.00 – VITAMIN D;
Prescription;
PRO DOC LIMITEE
DIN: 02417995
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90259
JAMP-VITAMIN D;
vitamin d3 10000 unit;
2015-11-20;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02449099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93491
AG-VITAMIN D;
vitamin d3 10000 unit;
2020-12-21;
Oral;
Tablet;
88:16.00 – VITAMIN D;
Prescription;
ANGITA PHARMA INC.
DIN: 02498944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98866
LUXA-D;
vitamin d3 2000 unit;
2015-07-31;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
ORIMED PHARMA INC
DIN: 02442256
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92661
EURO-D 50000 IU;
vitamin d3 50000 unit;
2011-08-09;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
EURO-PHARM INTERNATIONAL CANADA INC
DIN: 02371502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85666
JAMP-VITAMIN D;
vitamin d3 50000 unit;
2016-06-23;
Oral;
Capsule;
88:16.00 – VITAMIN D;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02449110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93493
VITAMIN K1 INJ 10MG/ML USP;
vitamin k1 10 mg / ml;
1989-12-31;
Intramuscular , Intravenous , Subcutaneous;
Emulsion;
88:24.00 – VITAMIN K ACTIVITY;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 00804312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9994
VITAMIN K1 INJ 1MG/0.5ML USP;
vitamin k1 2 mg / ml;
1989-12-31;
Intramuscular , Intravenous , Subcutaneous;
Emulsion;
88:24.00 – VITAMIN K ACTIVITY;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 00781878
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9993
VFEND;
voriconazole 200 mg;
2004-11-12;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
PFIZER CANADA ULC
DIN: 02256479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74171
TEVA-VORICONAZOLE;
voriconazole 200 mg;
2014-03-31;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
TEVA CANADA LIMITED
DIN: 02396874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88189
SANDOZ VORICONAZOLE;
voriconazole 200 mg;
2014-04-02;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02399253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88416
VFEND FOR INJECTION;
voriconazole 200 mg / vial;
2004-11-12;
Intravenous;
Powder For Solution;
08:14.08 – AZOLES;
Prescription;
PFIZER CANADA ULC
DIN: 02256487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74172
VORICONAZOLE FOR INJECTION;
voriconazole 200 mg / vial;
2014-04-30;
Intravenous;
Powder For Solution;
08:14.08 – AZOLES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02381966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86783
VORICONAZOLE FOR INJECTION;
voriconazole 200 mg / vial;
2019-07-23;
Intravenous;
Powder For Solution;
08:14.08 – AZOLES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02477696
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96863
VFEND;
voriconazole 200 mg / 5 ml;
2008-07-17;
Oral;
Powder For Suspension;
08:14.08 – AZOLES;
Prescription;
PFIZER CANADA ULC
DIN: 02279991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76561
VFEND;
voriconazole 50 mg;
2004-11-12;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
PFIZER CANADA ULC
DIN: 02256460
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74170
TEVA-VORICONAZOLE;
voriconazole 50 mg;
2014-03-31;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
TEVA CANADA LIMITED
DIN: 02396866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88187
SANDOZ VORICONAZOLE;
voriconazole 50 mg;
2014-04-02;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02399245
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88415
ZOLINZA;
vorinostat 100 mg;
2009-06-29;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MERCK CANADA INC
DIN: 02327619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81300
TRINTELLIX;
vortioxetine (vortioxetine hydrobromide) 10 mg;
2014-10-28;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
LUNDBECK CANADA INC
DIN: 02432927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91733
TRINTELLIX;
vortioxetine (vortioxetine hydrobromide) 20 mg;
2014-10-28;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
LUNDBECK CANADA INC
DIN: 02432943
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91735
TRINTELLIX;
vortioxetine (vortioxetine hydrobromide) 5 mg;
2014-10-28;
Oral;
Tablet;
28:16.04.24 – SEROTONIN MODULATORS;
Prescription;
LUNDBECK CANADA INC
DIN: 02432919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91732
TARO-WARFARIN;
warfarin sodium 1 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02242680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66470
APO-WARFARIN;
warfarin sodium 1 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
DIN: 02242924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66762
TARO-WARFARIN;
warfarin sodium 10 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02242687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66477
APO-WARFARIN;
warfarin sodium 10 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
DIN: 02242929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66767
TARO-WARFARIN;
warfarin sodium 2 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02242681
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66471
APO-WARFARIN;
warfarin sodium 2 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
DIN: 02242925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66763
TARO-WARFARIN;
warfarin sodium 2.5 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02242682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66472
APO-WARFARIN;
warfarin sodium 2.5 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
DIN: 02242926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66764
TARO-WARFARIN;
warfarin sodium 3 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02242683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66473
APO-WARFARIN;
warfarin sodium 3 mg;
2002-04-23;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
DIN: 02245618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69718
TARO-WARFARIN;
warfarin sodium 4 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02242684
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66474
APO-WARFARIN;
warfarin sodium 4 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
DIN: 02242927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66765
TARO-WARFARIN;
warfarin sodium 5 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02242685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66475
APO-WARFARIN;
warfarin sodium 5 mg;
2000-10-16;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
APOTEX INC
DIN: 02242928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66766
TARO-WARFARIN;
warfarin sodium 6 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02242686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66476
TARO-WARFARIN;
warfarin sodium 7.5 mg;
2000-08-09;
Oral;
Tablet;
20:12.04.08 – COUMARIN DERIVATIVES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02242697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66492
HYMENOPTERA VENOM PRODUCT-WASP VENOM PROTEIN (550 MCG);
wasp venom protein 550 mcg / vial;
1997-12-16;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
DIN: 02220091
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43272
STERILE WATER FOR INJECTION USP;
water 1 ml;
2009-08-31;
Intravascular;
Liquid;
40:50.00* – DILUENTS;
Otc;
MERCK CANADA INC
DIN: 02276097
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76176
STERILE WATER FOR IRRIGATION USP;
water 100 %;
1964-12-31;
Intraperitoneal , Irrigation , Topical;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00038229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=229
STERILE WATER FOR INJECTION USP;
water 100 %;
1951-12-31;
Intravenous;
Solution;
40:50.00* – DILUENTS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00038245
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1734
STERILE WATER FOR INJECTION USP;
water 100 %;
1978-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 00402257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3383
STERILE WATER FOR IRRIGATION USP;
water 100 %;
1980-12-31;
Intraperitoneal , Irrigation;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00498785
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3822
STERILE WATER FOR IRRIGATION, USP;
water 100 %;
1989-12-31;
Irrigation;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
DIN: 00799998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9831
STERILE WATER FOR INJECTION USP;
water 100 %;
1992-12-31;
Intravenous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
B. BRAUN MEDICAL INC
DIN: 01927930
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13509
STERILE WATER FOR INJECTION, USP;
water 100 %;
1994-12-31;
Intravenous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
BAXTER CORPORATION
DIN: 02014882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15867
BACTERIOSTATIC WATER FOR INJECTION USP;
water 100 %;
1994-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02131536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17402
STERILE WATER FOR INJECTION USP;
water 100 %;
1996-12-31;
Intravenous;
Liquid;
40:50.00* – DILUENTS;
Ethical;
BAXTER HEALTHCARE CORPORATION
DIN: 02214733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19812
STERILE WATER FOR INJECTION USP;
water 100 %;
1994-12-15;
Intramuscular , Intraperitoneal , Intravenous , Subcutaneous;
Solution;
40:50.00* – DILUENTS;
Ethical;
PFIZER CANADA ULC
DIN: 02142546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31491
STERILE WATER FOR INJECTION USP;
water 100 %;
2008-06-06;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:50.00* – DILUENTS;
Ethical;
TELIGENT OU
DIN: 02299186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78457
STERILE DILUENT FOR MERCK SHARP & DOHME CORP. LIVE ATTENUATED VIRUS VACCINES;
water 100 %;
2012-12-19;
Parenteral (Unspecified);
Liquid;
40:50.00* – DILUENTS;
Ethical;
MERCK CANADA INC
DIN: 02380811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86658
STERILISED WATER FOR INJECTIONS;
water 100 % / v/v;
2018-11-01;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:50.00* – DILUENTS;
Ethical;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02470861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95977
BACTERIOSTATIC WATER FOR INJECTION USP;
water 30 ml / 30 ml;
1952-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
40:50.00* – DILUENTS;
Ethical;
PFIZER CANADA ULC
DIN: 00038202
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=117
BACTERIOSTATIC WATER FOR INJECTION USP-PRE-FILLED SYRINGE;
water 99.1 %;
1996-07-30;
Intracavernosal;
Liquid;
40:50.00* – DILUENTS;
Ethical;
PFIZER CANADA ULC
DIN: 02215721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20354
HYMENOPTERA VENOM PRODUCT-WHITE-FACED HORNET VENOM PROTEIN (550 MCG);
white faced hornet venom protein 550 mcg / vial;
1997-12-06;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
DIN: 02220105
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43273
WHITE PETROLEUM JELLY USP OINTMENT;
white petrolatum 100 %;
1988-12-31;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CANADIAN CUSTOM PACKAGING COMPANY
DIN: 00741515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9587
PETROLATUM BLANC ONT USP;
white petrolatum 100 %;
1951-12-31;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
LABORATOIRE ATLAS INC
DIN: 00790516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41756
MEDI-WHITE PETROLEUM JELLY;
white petrolatum 100 %;
2006-06-06;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
MEDISCA PHARMACEUTIQUE INC
DIN: 02267691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75311
COMPLIMENTS WHITE PETROLEUM JELLY;
white petrolatum 100 %;
2009-05-31;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
GEMINI PACKAGING LTD
DIN: 02305178
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79066
PETROLEUM JELLY;
white petrolatum 100 %;
2014-03-06;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
CRLS
DIN: 02408821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89358
DIABETICS’ DRY SKIN RELIEF FOOT CREAM;
white petrolatum 30 % / w/w;
2015-02-23;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC
DIN: 02418347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90292
CRITIC-AID CLEAR;
white petrolatum 71.5 % / w/w;
2006-10-13;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
COLOPLAST A/S
DIN: 02277778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76338
COLD & ALLERGY RELIEF WITH MOISTURIZERS;
xylometazoline hydrochloride 0.1 %;
2003-02-01;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
PHARMASCIENCE INC
DIN: 02246023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70149
BALMINIL DECONGEST;
xylometazoline hydrochloride 0.1 %;
2007-12-14;
Nasal;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
DIN: 02300257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78557
OTRIVIN MEDICATED COMPLETE NASAL CARE;
xylometazoline hydrochloride 0.1 %;
2010-08-02;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02331403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81710
OTRIVIN MEDICATED COLD & ALLERGY RELIEF WITH MOISTURIZERS;
xylometazoline hydrochloride 0.1 % / w/v;
1996-10-15;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02208903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36767
OTRIVIN MEDICATED COLD & ALLERGY RELIEF;
xylometazoline hydrochloride 0.1 % / w/v;
1961-12-31;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 00653330
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41684
DECONGEST NASAL;
xylometazoline hydrochloride 0.1 % / w/v;
2007-12-20;
Nasal;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
DIN: 02300265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78558
COLD AND ALLERGY DECONGESTANT NASAL SPRAY;
xylometazoline hydrochloride 0.1 % / w/v;
2011-10-01;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
TEVA CANADA LIMITED
DIN: 02351927
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83716
DECONGESTANT NASAL SPRAY;
xylometazoline hydrochloride 0.1 % / w/v;
2017-03-07;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
CRLS
DIN: 02452812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93922
NASAL DECONGESTANT SPRAY WITH MOISTURIZERS;
xylometazoline hydrochloride 0.1 % / w/v;
2017-02-27;
Nasal;
Spray;
52:32.00 – VASOCONSTRICTORS;
Otc;
CRLS
DIN: 02452863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93927
YF-VAX;
yellow fever vaccine 109648 pfu / 0.5 ml;
1978-12-31;
Subcutaneous;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 00428833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2964
HYMENOPTERA VENOM PRODUCTS-YELLOW HORNET VENOM PROTEIN (550 MCG);
yellow hornet venom protein 550 mcg / vial;
1997-12-16;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
DIN: 02220083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43271
HYMENOPTERA VENOM PRODUCT – YELLOW JACKET VENOM PROTEIN (550 MCG);
yellow jacket venom protein 550 mcg / vial;
1997-12-16;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
DIN: 02220113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43274
YOHIMBINE TAB 5.4MG;
yohimbine hydrochloride 5.4 mg;
1991-12-31;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 01901885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12016
RELENZA;
zanamivir 5 mg / act;
1999-12-07;
Inhalation , Oral;
Powder;
08:18.28 – NEURAMINIDASE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02240863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64454
BRUKINSA;
zanubrutinib 80 mg;
2021-03-30;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BEIGENE SWITZERLAND GMBH
DIN: 02512963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100221
RETROVIR (AZT);
zidovudine 10 mg / ml;
1991-12-31;
Intravenous;
Liquid;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 01902644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11342
RETROVIR (AZT);
zidovudine 100 mg;
1990-12-31;
Oral;
Capsule;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 01902660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11300
APO-ZIDOVUDINE;
zidovudine 100 mg;
1992-12-31;
Oral;
Capsule;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 01946323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12839
RETROVIR (AZT);
zidovudine 50 mg / 5 ml;
1991-12-31;
Oral;
Syrup;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 01902652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11942
MICRO ZN;
zinc (zinc sulfate) 1 mg / ml;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00787019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13451
MICRO ZN;
zinc (zinc sulfate) 5 mg / ml;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00787000
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13416
ZELDOX;
ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg;
2008-01-04;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
UPJOHN CANADA ULC
DIN: 02298597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78389
AURO-ZIPRASIDONE;
ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg;
2018-03-19;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02449544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93537
ZELDOX;
ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg;
2008-01-04;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
UPJOHN CANADA ULC
DIN: 02298600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78392
AURO-ZIPRASIDONE;
ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg;
2018-03-19;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02449552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93538
ZELDOX;
ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg;
2008-01-04;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
UPJOHN CANADA ULC
DIN: 02298619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78393
AURO-ZIPRASIDONE;
ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg;
2018-03-19;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02449560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93539
ZELDOX;
ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg;
2008-01-04;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
UPJOHN CANADA ULC
DIN: 02298627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78394
AURO-ZIPRASIDONE;
ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg;
2018-03-19;
Oral;
Capsule;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
AURO PHARMA INC
DIN: 02449579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93540
ZOMETA CONCENTRATE;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2004-10-14;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02248296
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72636
ZOLEDRONIC ACID – Z;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2014-01-15;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02401606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88649
ZOLEDRONIC ACID FOR INJECTION;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2014-02-26;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02407639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89236
TARO-ZOLEDRONIC ACID CONCENTRATE;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2014-02-26;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02415186
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89980
ZOLEDRONIC ACID FOR INJECTION CONCENTRATE;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2014-05-28;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
DR REDDY’S LABORATORIES LTD
DIN: 02422425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90711
ZOLEDRONIC ACID FOR INJECTION;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2016-02-10;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02434458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91878
ZOLEDRONIC ACID FOR INJECTION;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2016-04-27;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
JUNO PHARMACEUTICALS CORP.
DIN: 02444739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92989
ZOLEDRONIC ACID FOR INJECTION;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2019-01-29;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02472805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96212
JAMP-ZOLEDRONIC ACID;
zoledronic acid (zoledronic acid monohydrate) 4 mg / 5 ml;
2020-01-20;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02482525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97282
ACLASTA;
zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 ml;
2005-08-22;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02269198
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75458
TARO-ZOLEDRONIC ACID;
zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 ml;
2014-04-02;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02415100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89972
ZOLEDRONIC ACID INJECTION;
zoledronic acid (zoledronic acid monohydrate) 5 mg / 100 ml;
2014-05-28;
Intravenous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
DR REDDY’S LABORATORIES LTD
DIN: 02422433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90712
ZOMIG;
zolmitriptan 2.5 mg;
1998-09-30;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02238660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62089
ZOMIG RAPIMELT;
zolmitriptan 2.5 mg;
2001-03-05;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02243045
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66907
TEVA-ZOLMITRIPTAN;
zolmitriptan 2.5 mg;
2011-06-07;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02313960
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79948
PMS-ZOLMITRIPTAN ODT;
zolmitriptan 2.5 mg;
2011-06-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02324768
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81019
TEVA-ZOLMITRIPTAN OD;
zolmitriptan 2.5 mg;
2011-06-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02342545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82803
SANDOZ ZOLMITRIPTAN;
zolmitriptan 2.5 mg;
2011-06-07;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02362988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84796
SANDOZ ZOLMITRIPTAN ODT;
zolmitriptan 2.5 mg;
2011-06-07;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02362996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84797
MINT-ZOLMITRIPTAN;
zolmitriptan 2.5 mg;
2014-03-18;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02419521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90415
NAT-ZOLMITRIPTAN;
zolmitriptan 2.5 mg;
2015-02-17;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02421534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90614
JAMP-ZOLMITRIPTAN;
zolmitriptan 2.5 mg;
2014-03-13;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02421623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90627
JAMP-ZOLMITRIPTAN ODT;
zolmitriptan 2.5 mg;
2014-09-14;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02428237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91271
ZOLMITRIPTAN;
zolmitriptan 2.5 mg;
2015-10-14;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02442655
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92700
ZOLMITRIPTAN ODT;
zolmitriptan 2.5 mg;
2015-10-14;
Oral;
Tablet (Orally Disintegrating);
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02442671
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92701
CCP-ZOLMITRIPTAN;
zolmitriptan 2.5 mg;
2019-01-04;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02458780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94593
JAMP ZOLMITRIPTAN;
zolmitriptan 2.5 mg;
2020-02-21;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02477106
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96780
AURO-ZOLMITRIPTAN;
zolmitriptan 2.5 mg;
2020-03-18;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02481030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97162
NRA-ZOLMITRIPTAN;
zolmitriptan 2.5 mg;
2020-07-06;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
NORA PHARMA INC
DIN: 02489392
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97948
ZOMIG NASAL SPRAY;
zolmitriptan 2.5 mg / act;
2004-12-23;
Nasal , Oral;
Spray;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02248992
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73377
ZOMIG NASAL SPRAY;
zolmitriptan 5 mg / act;
2004-12-23;
Nasal , Oral;
Spray;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02248993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73378
SUBLINOX;
zolpidem tartrate 10 mg;
2011-11-29;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
BAUSCH HEALTH, CANADA INC.
DIN: 02370433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85559
APO-ZOLPIDEM ODT;
zolpidem tartrate 10 mg;
2015-02-13;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
APOTEX INC
DIN: 02434946
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91923
PMS-ZOLPIDEM ODT;
zolpidem tartrate 10 mg;
2016-12-13;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
DIN: 02436183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92052
MINT-ZOLPIDEM ODT;
zolpidem tartrate 10 mg;
2021-03-19;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
MINT PHARMACEUTICALS INC
DIN: 02472848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96217
SUBLINOX;
zolpidem tartrate 5 mg;
2013-01-28;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
BAUSCH HEALTH, CANADA INC.
DIN: 02391678
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87699
APO-ZOLPIDEM ODT;
zolpidem tartrate 5 mg;
2015-02-13;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
APOTEX INC
DIN: 02436159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92048
PMS-ZOLPIDEM ODT;
zolpidem tartrate 5 mg;
2016-12-13;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
DIN: 02436175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92051
MINT-ZOLPIDEM ODT;
zolpidem tartrate 5 mg;
2021-03-19;
Sublingual;
Tablet (Orally Disintegrating);
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Targeted (Cdsa Iv);
MINT PHARMACEUTICALS INC
DIN: 02472821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96216
PMS-ZOPICLONE;
zopiclone 3.75 mg;
2017-01-01;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02458543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94567
JAMP-ZOPICLONE TABLETS;
zopiclone 3.75 mg;
2018-09-26;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02468395
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95682
AG-ZOPICLONE;
zopiclone 3.75 mg;
2018-12-21;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96652
M-ZOPICLONE;
zopiclone 3.75 mg;
2019-02-06;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MANTRA PHARMA INC
DIN: 02482800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97321
PRIVA-ZOPICLONE;
zopiclone 3.75 mg;
2020-09-29;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMAPAR INC
DIN: 02492407
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98242
IMOVANE;
zopiclone 5 mg;
1998-02-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02216167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43171
PMS-ZOPICLONE;
zopiclone 5 mg;
2001-02-15;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02243426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67334
APO-ZOPICLONE;
zopiclone 5 mg;
2002-06-04;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
APOTEX INC
DIN: 02245077
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69081
TEVA-ZOPICLONE;
zopiclone 5 mg;
2002-12-18;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02246534
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70717
TARO-ZOPICLONE;
zopiclone 5 mg;
2005-07-05;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02267918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75330
ACT ZOPICLONE;
zopiclone 5 mg;
2005-11-11;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02271931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75747
RIVA-ZOPICLONE;
zopiclone 5 mg;
2006-10-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02278030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76362
PRO-ZOPICLONE;
zopiclone 5 mg;
2008-07-09;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02313065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79861
ZOPICLONE;
zopiclone 5 mg;
2010-02-25;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02344122
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82952
ZOPICLONE;
zopiclone 5 mg;
2012-06-11;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87144
MAR-ZOPICLONE;
zopiclone 5 mg;
2013-04-17;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02386771
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87237
MINT-ZOPICLONE;
zopiclone 5 mg;
2012-10-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02391716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87703
JAMP-ZOPICLONE TABLETS;
zopiclone 5 mg;
2014-01-08;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02406969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89162
PRIVA-ZOPICLONE;
zopiclone 5 mg;
2015-06-03;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMAPAR INC
DIN: 02425874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91052
M-ZOPICLONE;
zopiclone 5 mg;
2018-04-16;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MANTRA PHARMA INC
DIN: 02467941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95631
ZOPICLONE;
zopiclone 5 mg;
2018-08-07;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ALTAMED PHARMA
DIN: 02468492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95692
AG-ZOPICLONE;
zopiclone 5 mg;
2018-07-25;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96656
NRA-ZOPICLONE;
zopiclone 5 mg;
2018-08-30;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
NORA PHARMA INC
DIN: 02477378
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96835
BIO-ZOPICLONE;
zopiclone 5 mg;
2019-06-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
BIOMED PHARMA
DIN: 02481006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97135
IMOVANE;
zopiclone 7.5 mg;
1990-12-31;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 01926799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12426
APO-ZOPICLONE;
zopiclone 7.5 mg;
1996-09-19;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
APOTEX INC
DIN: 02218313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43233
PMS-ZOPICLONE;
zopiclone 7.5 mg;
1999-08-04;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMASCIENCE INC
DIN: 02240606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64177
TEVA-ZOPICLONE;
zopiclone 7.5 mg;
2001-04-18;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02242481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66208
TARO-ZOPICLONE;
zopiclone 7.5 mg;
2005-07-05;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02267926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75331
ACT ZOPICLONE;
zopiclone 7.5 mg;
2005-11-11;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02271958
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75748
RIVA-ZOPICLONE;
zopiclone 7.5 mg;
2008-11-14;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02278049
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76363
ZOPICLONE;
zopiclone 7.5 mg;
2010-02-25;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANIS HEALTH INC
DIN: 02282445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76809
PRO-ZOPICLONE;
zopiclone 7.5 mg;
2008-07-09;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PRO DOC LIMITEE
DIN: 02313073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79862
ZOPICLONE;
zopiclone 7.5 mg;
2012-06-11;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87145
MAR-ZOPICLONE;
zopiclone 7.5 mg;
2013-04-17;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02386798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87238
MINT-ZOPICLONE;
zopiclone 7.5 mg;
2012-10-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02391724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87704
JAMP-ZOPICLONE TABLETS;
zopiclone 7.5 mg;
2014-11-19;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02406977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89163
PRIVA-ZOPICLONE;
zopiclone 7.5 mg;
2015-06-03;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PHARMAPAR INC
DIN: 02425882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91053
M-ZOPICLONE;
zopiclone 7.5 mg;
2018-04-16;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
MANTRA PHARMA INC
DIN: 02467968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95632
ZOPICLONE;
zopiclone 7.5 mg;
2018-08-07;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ALTAMED PHARMA
DIN: 02469154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95781
AG-ZOPICLONE;
zopiclone 7.5 mg;
2018-07-25;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ANGITA PHARMA INC.
DIN: 02475847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96657
NRA-ZOPICLONE;
zopiclone 7.5 mg;
2018-08-30;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
NORA PHARMA INC
DIN: 02477386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96836
BIO-ZOPICLONE;
zopiclone 7.5 mg;
2019-06-10;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
BIOMED PHARMA
DIN: 02481014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97136
CLOPIXOL TABLETS 10MG;
zuclopenthixol (zuclopenthixol hydrochloride) 10 mg;
1997-05-02;
Oral;
Tablet;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
DIN: 02230402
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49241
CLOPIXOL TABLETS 25MG;
zuclopenthixol (zuclopenthixol hydrochloride) 25 mg;
1997-05-02;
Oral;
Tablet;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
DIN: 02230403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49242
CLOPIXOL-ACUPHASE 50MG/ML;
zuclopenthixol acetate 50 mg / ml;
1997-05-02;
Intramuscular;
Solution;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
DIN: 02230405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49244
CLOPIXOL DEPOT 200MG/ML;
zuclopenthixol decanoate 200 mg / ml;
1997-05-02;
Intramuscular;
Solution;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
DIN: 02230406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49245

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut